{
  "name" : "_cyber.sci-hub.se_MTAuMTE2Ni9qYm4uMjAxNi4yMTIy_chen2016.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Inorganic Nanomaterials as Carriers for Drug Delivery",
    "authors" : [ "Shizhu Chen", "Xiaohong Hao", "Xingjie Liang", "Qun Zhang", "Cuimiao Zhang", "Guoqiang Zhou", "Shigang Shen", "Guang Jia", "Jinchao Zhang" ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : null,
      "text" : "Delivered by Publishing Technology to: Rice University IP: 208.98.249.39 On: Wed, 23 Dec 2015 17:22:25\nCopyright: American Scientific Publishers\nCopyright © 2016 American Scientific Publishers All rights reserved Printed in the United States of America\nReview Journal of\nBiomedical Nanotechnology Vol. 12, 1–27, 2016 www.aspbs.com/jbn"
    }, {
      "heading" : "Inorganic Nanomaterials as Carriers for Drug Delivery",
      "text" : ""
    }, {
      "heading" : "Shizhu Chen1, Xiaohong Hao1, Xingjie Liang2, Qun Zhang1, Cuimiao Zhang1, Guoqiang Zhou1, Shigang Shen1, Guang Jia1 ∗, and Jinchao Zhang1 ∗",
      "text" : "1Key Laboratory of Chemical Biology of Hebei Province, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, College of Chemistry and Environmental Science, Hebei University, Baoding 071002, P. R. China 2CAS Key Lab of Nanomaterials Bioeffects and Nanosafety, National Center for Nanoscience and Technology of China, Beijing, 100190, P. R. China\nFor safe and effective therapy, drugs must be delivered efficiently and with minimal systemic side effects. Nanostructured drug carriers enable the delivery of small-molecule drugs as well as nucleic acids and proteins. Inorganic nanomaterials are ideal for drug delivery platforms due to their unique physicochemical properties, such as facile preparation, good storage stability and biocompatibility. Many inorganic nanostructure-based drug delivery platforms have been prepared. Although there are still many obstacles to overcome, significant advances have been made in recent years. This review focuses on the status and development of inorganic nanostructures, including silica, quantum dots, gold, carbon-based and magnetic iron oxide-based nanostructures, as carriers for chemical and biological drugs. We specifically highlight the extensive use of these inorganic drug carriers for cancer therapy. Finally, we discuss the most important areas in the field that urgently require further study.\nKEYWORDS: Inorganic Nanodrug Carriers, Mesoporous Silica, Quantum Dot, Carbon, Gold, Magnetic Iron Oxide."
    }, {
      "heading" : "CONTENTS",
      "text" : "Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 Mesoporous Silica Nanoparticles for Drug Delivery Systems . . . . 4\nStructure and Morphology of Mesoporous Silica Nanoparticles for Drug Delivery . . . . . . . . . . . . . . . . . . . . 4 Functionalized Mesoporous Silica Nanoparticles for Drug Delivery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Stimuli-Responsive Mesoporous Silica Nanoparticles for Drug Delivery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 QD-Based Nanostructures for Drug Delivery Systems . . . . . . . . 7 QDs as Drug Delivery Vehicles . . . . . . . . . . . . . . . . . . . . 8 QDs as Tags for Other Drug Delivery Vehicles . . . . . . . . . . 8 Carbon-Based Nanostructures for Drug Delivery Systems . . . . . . 10 Carbon Nanoparticles . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Fullerenes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Graphene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Carbon Nanotubes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Diamonds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Gold Nanostructures as Drug Delivery Systems . . . . . . . . . . . . 12 Gold Nanospheres . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Gold Nanorods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Gold Nanocages . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15\n∗Authors to whom correspondence should be addressed. Emails: guangjia2001@163.com, jczhang6970@163.com Received: 17 January 2014 Revised/Accepted: 1 June 2014\nMagnetic Iron Oxide-Based Nanostructures for Drug Delivery Systems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16\nInorganic Material Coating . . . . . . . . . . . . . . . . . . . . . . . 16 Polymer Coating . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17 Other Material Coatings . . . . . . . . . . . . . . . . . . . . . . . . . 18 Summary and Outlook . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21 Acknowledgment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21 References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21"
    }, {
      "heading" : "INTRODUCTION",
      "text" : "Drug delivery is a field of vital importance to medicine and healthcare. Controlled drug delivery systems that can deliver therapeutic drugs to targeted cells or tissues in a controlled manner can improve bioavailability by preventing premature degradation and enhancing uptake, maintain drug concentration within the therapeutic window by controlling the drug release rate, and reduce side effects by targeting only the disease site or target cells.1 2 Over the past decade, nanotechnology has played an increasingly important role in the field of drug delivery.3 Various nanostructured inorganic materials are being developed as ideal drug carriers due to their unique nanostructure construction, functional properties, and controlled drug-release behaviors. Moreover, nanoscale inorganic drug carriers exhibit excellent compatibility with and sustained release patterns\nJ. Biomed. Nanotechnol. 2016, Vol. 12, No. 1 1550-7033/2016/12/001/027 doi:10.1166/jbn.2016.2122 1\nDelivered by Publishing Technology to: Rice University IP: 208.98.249.39 On: Wed, 23 Dec 2015 17:22:25\nCopyright: American Scientific Publishers\nof water-insoluble drugs as well as protein, DNA, and RNA therapeutics.4\nFunctional nanomaterials with excellent mesoporous, luminescent, magnetic, and/or surface properties exhibit unique size-, shape-, and composition-dependent physical\nShizhu Chen is a master fellow in the laboratories of Professor Jinchao Zhang at the College of Chemistry and Environmental Science from Hebei University (Chemical Biology Key Laboratory of Hebei Province). His current research interest focuses on the biological effects of manufactured nanomaterials including the functionalized cerium oxide nanoparticles and NaYF4. His previous work includes the research of antioxidative properties of cerium oxide nanoparticles, which protect the endothelial and osteoblast cells from injury by oxidative stress, and the toxicity of NaYF4 nanoparticles on the endothelial cells.\nXiaohong Hao obtained her B.S. and M.S. degrees from Hebei University. As a master student she worked under the guidance of the professor Jinchao Zhang at the Chemical Biology Key Laboratory of Hebei Province. During this time, she was also as a joint-supervision of National Center for Nanoscience and Technology. Her current research interests focuses on the biological effects of manufactured nanomaterials and the synthesis of new materials for nanomedicine.\nXingjie Liang got Ph.D. at National Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences. He finished his postdoc with Dr. Michael M. Gottesman (Deputy Director of NIH, USA) for 5 years at Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health. Dr. Liang currently is deputy director of Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences and a principal investigator at National Center for Nanoscience and Technology of China. He is current Associate Editors of Biomaterials and Biophysics Report; Advisory editorial board member of ACS Nano; Editorial member of Advances in Nano Research, Current Nanoscience, Biomaterials Research, Theranostics and guest editor of Biotechnology Advances. His research interests are in elucidating mechanisms to improve nanomedicinal bioavail-\nability by nanotechnology in vitro and in vivo, and novel strategies to increase therapeutic effect on cancers and infective diseases.\nQun Zhang received a bachelor of chemistry from Hebei Normal University in 2010. In 2013, she worked under the guidance of Professor Jinchao Zhang and received a master’s degree of biochemistry from Hebei University. Since 2013, she has been a Ph.D. in Department of Chemical Biology, Peking University Health Science Center. Her work includes the research about the anti-leukemia drugs and the effects of rare earth elements and rare earth nanoparticles on the proliferation, osteogenic differentiation, adipogenic differentiation and mineralization of primary mouse bone marrow stromal cells at cell and molecular levels.\nand chemical properties. These features make them attractive materials for drug delivery and therapeutic and diagnostic applications. The use of nanomaterials for diagnostic or therapeutic purposes is defined as “nanomedicine” and has developed rapidly in recent\n2 J. Biomed. Nanotechnol. 12, 1–27, 2016\nDelivered by Publishing Technology to: Rice University IP: 208.98.249.39 On: Wed, 23 Dec 2015 17:22:25\nCopyright: American Scientific Publishers\nCuimiao Zhang received her B.S. (2004) in chemistry from Hebei University. Then she has been a graduate student in Jun Lin’s group at Changchun Institute of Applied Chemistry (CIAC), Chinese Academy of Sciences, and received a Ph.D. degree in 2010. After graduation, she has been working as a research fellow in Nanyang Technological University (Singapore, 2010–2012). Her current research interests include the synthesis of environmentally-friendly luminescence materials and their bio-applications.\nGuoqiang Zhou received his Ph.D. at Institute for High Energy Physics, Chinese Academy of Sciences. He joined the Hebei University in 2009, now he is an associate professor and the postgraduate tutor in the College of Chemistry and Environmental Science in Hebei University. His research interests include the studies on the nanomaterials’ biological effects and safety evaluation, the synthesis of nanomaterials and its application in biomedicine.\nShigang Shen is the professor of chemistry at Hebei University, where he obtained the Ph.D. degree of analytical chemistry in 2002. He is the member of Chinese Chemical Society. His research interests include studies on synthesis of antitumor Pt(IV) complexes, kinetics and mechanism for reduction these Pt(IV) complexes by thiol-containing compounds, and synthesis of intramolecular disulfide bonds in peptides using Pt(IV) complexes.\nGuang Jia was born in Hebei, China in 1981. He received his B.S. (2004) and M.S. degrees from Hebei University. Then he has been a graduate student at Changchun Institute of Applied Chemistry (CIAC), Chinese Academy of Sciences, and received a Ph.D. degree in inorganic chemistry in 2010. Since then he has been working as an associate professor in Hebei University. He has published more than 50 papers in reputed international journals. His current research interests include the synthesis and properties of rare earth and other multifunctional inorganic luminescent nanomaterials together with their applications in displays, lighting, and biomedical fields.\ndecades.5 6 For nanomedicine applications, the design and synthesis of precisely tailor-made nanostructures is essential. In particular, multifunctional drug delivery systems in which two or more components are incorporated to give multifunctional capabilities have shown great promise in the treatment and diagnosis of disease due to their ability to target and treat specific sites while permitting noninvasive monitoring of particle localization.7 8 These multifunc-\ntional drug delivery systems have attracted considerable attention and have played an increasingly important role in realizing the full potential of next-generation therapeutics. In this review, we provide a critical summary of various\nnanostructures based on mesoporous silica, quantum dots (QDs), carbon, gold, and magnetic iron oxide, followed by a discussion of the influence of nanostructure-based drug delivery on crucial biological processes. Moreover, we\nJ. Biomed. Nanotechnol. 12, 1–27, 2016 3\nDelivered by Publishing Technology to: Rice University IP: 208.98.249.39 On: Wed, 23 Dec 2015 17:22:25\nCopyright: American Scientific Publishers\nJinchao Zhang obtained his Ph.D. in Chemistry from Zhejiang University (2001) and postdoctoral training in the Peking University (2001–2003) and City University of Hong Kong (2003–2006). He joined the Hebei University in 2007. Now he is the professor of Hebei University, the Ph.D. supervisor, the winner of Hebei Province Science Fund for Distinguished Young Scholars, the member of National Bio-inorganic Chemistry Academic Committee, the Director of Chemical Biology Key Laboratory of Hebei Province, and the Director of Nanometer Medical Center of Hebei University. Professor Zhang has published over 80 peer-reviewed scientific papers and 12 patents/patent applications. Now Dr. Zhang’s group is developing novel nanomaterial for biological functions and applications.\nhighlight the development of novel, multi-functionalized, stimuli-responsive nanostructured drug carriers with targeting, imaging, and stimuli-responsive functionalities and their potential applications in drug delivery systems."
    }, {
      "heading" : "MESOPOROUS SILICA NANOPARTICLES FOR DRUG DELIVERY SYSTEMS",
      "text" : "In the past decade, mesoporous silica nanoparticles have attracted considerable attention for their potential biomedical applications due to their tailored mesoporous structure, large surface area, good biocompatibility, and ease of surface functionalization.7 9 Due to these unique properties, mesoporous silica nanoparticles have become attractive nanocontainers for drug deliver systems.10 11\nThese properties also provide unique opportunities to develop multimodal theranostic nanoparticles.12 Therefore, multifunctional mesoporous silica-based nanocomposites have stood out as an ideal platform due to their potential for simultaneous diagnosis and therapy.1 13"
    }, {
      "heading" : "Structure and Morphology of Mesoporous Silica Nanoparticles for Drug Delivery",
      "text" : "Undoubtedly, mesoporous silica nanoparticles are one of the most well-known carriers for drug delivery. However, the textural properties (e.g., pore diameter, surface area, and pore volume), various mesostructures (e.g., disordered, wormhole-like, hexagonal, cubic, and lamellar mesophases), and morphology (e.g., spheres, hollow spheres, core–shell, rattle-type hierarchical structures, nanofibers, nanotubules) of mesoporous silica nanoparticles greatly affect drug loading amounts and release rates. Thus, rational control over these properties has become an important research area.14\nEmerging mesoporous silica materials have led to a variety of important applications because of their unique properties, which include stable mesoporous structures, uniform and tunable pore size, and high silanol-containing surface area and volume. Earlier mesoporous silica materials mainly focused on physical and textural properties, and a series of pure mesoporous silica materials were synthesized, such as MCM-41, MCM-48, and SBA-15, with different structural characteristics.15\nOrdered mesoporous silica nanoparticle drug carriers have attracted considerable attention since Vallet-Regí et al. reported the first application of mesoporous silica nanoparticles as a drug delivery system in 2001.16\nIbuprofen was loaded into the mesopores of MCM41-type mesoporous silica nanoparticles, which exhibited high drug loading capacity and sustained drug release. The influence of textural parameters on the drug loading amount and release rate was systematically investigated.16 17 The structure of the channel and the cavity topology in ordered mesoporous silica nanoparticles also appear to influence the drug loading and release rate. The different porous structures of MCM-48 (3D cubic) and MCM-41 (2D hexagonal), which have similar pore sizes, have a rather weak influence on the in vitro release kinetic profiles of ibuprofen.18 In addition to pore size, surface area is another important factor governing the amount of drug molecules because drug loading is mainly an adsorption process. High specific surface areas increase molecular retention, slowing the release rate.19\nHollow structures have attracted attention in both fundamental research and practical applications because of their unique properties, such as a porous shell, low density, high surface-to-volume ratio, and low coefficients of thermal expansion.20 With the rapid development of fabrication procedures and applications, the demand for mesoporous silica nanoparticles with special hollow structures has gradually increased. Hollow mesoporous silica possesses both large internal voids and many external mesopores on the shell, resulting in low density and a high specific area. Shi’s group synthesized various spherical/ellipsoidal hollow mesoporous silica nanostructures using hard-template, micellar aggregate template, and co-templates routes.21–23\nThe hollow nanostructures possessed internal voids and mesoporous shells that enabled facile modification with functional groups, permitting advantageous interactions with biologically active molecules, effective control of drug adsorption and a sustained release rate. Moreover, Shi and co-workers reported that a class of highly dispersed hollow mesoporous silica structures with controllable particle/pore sizes displayed high loading capacity for the anticancer drug DOX. Hollow mesoporous silica spheres\n4 J. Biomed. Nanotechnol. 12, 1–27, 2016\nDelivered by Publishing Technology to: Rice University IP: 208.98.249.39 On: Wed, 23 Dec 2015 17:22:25\nCopyright: American Scientific Publishers\nwith large pores also enabled the rapid immobilization of protein-based biomolecules (hemoglobin).24\nEmerging rattle-type/yolk-type mesoporous silica-based nanomaterials, which possess interstitial hollow spaces and mesoporous shells similar to those found in hollow mesoporous silica, are also ideal new-generation drug delivery systems with special functions and extraordinarily high loading capacities. These types of nanostructures are generally based on hollow mesoporous silica nanospheres with metal, magnetic, or phosphor cores and have attracted considerable attention due to their potential as multifunctional drug delivery systems for imaging, targeting, and drug delivery applications.25 26 In one pioneering work, Chen et al. successfully synthesized rattle-type Au@mSiO2 and Fe2O3@mSiO2 nanostructures through a novel etching strategy. The Au@mSiO2 rattle structure could be used to diagnose and treat diseases due to its strong plasmonenhanced absorption, the high light-scattering ability of Au, and the well-defined mesopores of the mesoporous silica shell for drug loading and controlled release.27\nSubsequently, Huang et al. prepared multi-shelled mesoporous silica nanospheres for drug delivery systems by self-templated synthesis involving interior channel wall protection as well as outermost surface passivation.28 The shell-to-shell distance could be tuned by controlling the etching period from the self-template processes without changing the multi-shelled size or interior core diameter. This novel multi-shelled mesoporous nanostructure provided a platform for the development of a multifunctional vector via the inclusion of functional species in shell-toshell cavities and porous shells. Recently, mesoporous silica nanotubes have emerged as another type of carrier for drug delivery systems. Mesostructured silica nanotubes have three different types of surfaces: the outer surface, the inner surface of the central tubular cavity, and the internal surface of the tubule sheath. All three types of surfaces can be modified for better performance. Modifying the open ends of silica nanotubes is highly critical for facilitating drug uptake and controlled release for the development of elaborate drug delivery systems.29\nSurface-functionalized, end-capped porous silica nanomaterials can also be used to fabricate stimuli-responsive carriers for controlled drug delivery. Yu et al. successfully developed an efficient method to modify the open ends of mesoporous silica nanotubes with Au, Ag, and polylacticco-glycolic acid (PLGA), enabling improved drug delivery.30\nIn addition to structure and morphology, particle size can strongly affect the efficiency of in vivo delivery and cellular uptake.7 31 For effective drug delivery, the size of therapeutic nanocomposite particles should be smaller than 100 nm because of the high colloidal stability in physiological environments and long blood circulation times of particles of this size."
    }, {
      "heading" : "Functionalized Mesoporous Silica Nanoparticles for Drug Delivery",
      "text" : "In the past several decades, significant research efforts have been devoted to developing multifunctional nanomedical platforms for multimodal imaging, simultaneous diagnosis, and targeting therapy.7 Functionalized mesoporous silica-based materials with excellent magnetic and/or luminescent properties have shown great promise as an ideal system for drug delivery. Magnetic nanoparticles have attracted attention for drug\ndelivery applications because they allow drugs to be targeted to the desired location by means of an external magnetic field. Such targeting ability is crucial because many drugs, particularly cancer drugs, have significant toxic effects. Magnetic materials, particularly iron oxides, are prone to aggregation due to the anisotropic dipolar attractions and rapid biodegradation that occur when they are exposed to biological systems.32 Iron oxide magnetic particles have been combined with mesoporous silica matrixes to overcome these limitations, representing a significant advance in the drug delivery field.15 33 These iron oxide/mesoporous silica composite materials have potential for use in anticancer drug delivery. Luminescence-functionalized mesoporous silica drug\ncarriers, which can be easily identified, tracked, and monitored to evaluate the efficiency of drug release and disease therapy, have recently become a focus in nanom dicine. The current luminescent emitters for drug delivery include organic dyes, semiconductor nanocrystals, and rare earth nanophosphors. Traditionally, the organic dyes most commonly used as biological luminescent labels are fluorescein isothiocyanates, rhodamine, and cyanine dyes.34 In the past decade, colloidal II–VI semiconductor QDs have attracted considerable attention as labels in biological imaging and detection. Kim et al. developed a surfactant templated mesoporous silica coating method to yield QD composites that exhibited excellent luminescence properties and biocompatibility and that could be utilized as luminescence-functionalized drug carriers.35 Another excellent luminescent material for drug delivery systems is rare earth-based phosphors, which exhibit intense narrow-band intra-4f luminescence in a wide range of hosts. Lin’s group has designed a number of down-conversion and up-conversion rare earth-doped nanophosphor-functionalized (including Y2O3:Eu\n3+, YVO4:Eu3+, CeF3:Tb3+, Gd2O3:Eu3+, Gd2O3:Er\n3+, NaYF4:Yb3+/Er3+, etc.,) mesoporous silica composites for sustained drug delivery that exhibit nontoxicity, satisfactory biocompatibility, good stability, and sustained release.36–38 Infrared-to-visible up-conversion phosphors have promising potential as alternatives to traditional dyes and QDs due to their high photostability, high detection sensitivity, negligible photodamage to living organisms, and high light excitation-penetration depths for NIR irradiation in tissues.39 40\nJ. Biomed. Nanotechnol. 12, 1–27, 2016 5\nDelivered by Publishing Technology to: Rice University IP: 208.98.249.39 On: Wed, 23 Dec 2015 17:22:25\nCopyright: American Scientific Publishers\nDue to their unique structure, high chemical stability, non-toxicity, and ease of surface functionalization, mesoporous silica nanoparticles constitute a multifunctional platform for drug delivery. Many studies have focused on the design of mesoporous-silica-based multifunctional drug delivery systems, particularly by combining luminescence and magnetism in the mesoporous silica matrix. These multifunctional hybrid materials can target diseased tissues and enable the visualization of drug delivery in real time during controlled drug release.15 Yang et al. synthesized core–shell structured multifunctional hybrid drug delivery systems using silica-coated Fe3O4 nanospheres as the core, ordered mesoporous silica as the shell, and further deposition of phosphors (YVO4:Eu\n3+ or NaYF4:Yb, Er/Tm).\n41 The core–shell structured systems exhibited characteristic down- and up-conversion emission and high magnetization. Interestingly, the drug release process of the multifunctional carriers could be tracked and monitored based on changes in the photoluminescence intensities. By combining targeting and dual-imaging capability, multifunctional nanoparticles might be applied in the imaging and drug delivery fields."
    }, {
      "heading" : "Stimuli-Responsive Mesoporous Silica Nanoparticles for Drug Delivery",
      "text" : "Sustained-release systems in which drugs are physically adsorbed in mesoporous silica channels may cause immediate drug release after administration, resulting in undesirable side effects to normal cells and organs. Stimuli-responsive drug carriers that undergo abrupt changes in response to external stimuli, such as pH, temperature, redox environment, and biomolecules, have been regarded as “intelligent” drug delivery systems. Composite materials combined with mesoporous silica and various stimuli-responsive components block drug release under undesirable conditions, and release is triggered only upon exposure to stimuli signals to achieve “intelligent” drug release. The development of mesoporous silica-based stimuli-responsive controlled drug delivery systems has attracted increasing attention. Among the reported stimuli-responsive drug delivery\nsystems, pH-responsive systems are the most attractive because the human body exhibits variations in pH value along the gastrointestinal tract from the stomach to the small intestine and then to the colon. These pH-sensitive human systems and tissues offer an efficient means of controlling drug release behavior using pH stimuli.42 Zink’s group has developed several pHresponsive mesoporous silica drug carriers containing pHsensitive pseudorotaxanes, rotaxanes, and other molecules. In these systems, aromatic amines/ammonium stalks were immobilized on the surfaces of mesoporous silica nanoparticles, and large ring movable gates were introduced to encircle the stalks to control the flow of the drug models loaded in the pore channels.43 44 Li et al. synthesized\nmultifunctional magnetic-fluorescent pH-responsive ecc(con-Fe3O4@SiO2)@polyacrylic acid core-double shell nanocrystals as tracing labels and drug delivery vehicles to function as pH-responsive nanoreservoirs and fluorescent trackers for efficient targeted drug delivery to cancer cells.45 Zhu et al. designed a novel pHresponsive controlled drug delivery system using polycation poly(allylamine hydrochloride)/sodium polystyrene sulfonate multilayers as a coating to cap the mesopore openings of drug-loaded hollow silica spheres.46\nResearch on temperature-responsive drug carriers has mainly focused on mesoporous silica/poly(N -isopropyl acrylamide) (PNiPAM) composites.47 48 Lin and coworkers demonstrated a feasible route for the synthesis of multicompartment drug carriers containing a luminescent rattle-type mesoporous silica microsphere filled with a thermosensitive P(NiPAM-co-AAm) hydrogel as a temperature-controlled switch. The multifunctional carriers exhibited a remarkable positive temperaturesensitive on–off modulation for indomethacin release; i.e., they displayed rapid drug release at higher temperatures (on phase) and ceased drug release at lower temperatures (off phase).49 Schlossbauer50 and Ruiz-Hernández51 developed a novel DNA-based thermo-responsive drug delivery system in which biotin-labeled DNA double strands and DNA/magnetic nanoparticles were used to cap the pores of mesoporous silica nanoparticles. The opening of the valve and the subsequent release of the drug were achieved by DNA strand melting at the specific DNA melting temperature. Thermo- and pH-responsive polymer-shell-coated meso-\nporous silica nanoparticles have recently been developed for drug delivery with controllable drug release that precisely matches the actual physiological needs at the proper time and site. Our group has also reported multifunctional hybrid PNiPAM/AA@SiO2 nanoparticles for controlled DOX loading and release with a thermal and pH dual response.52 The drug release results indicated that the PNiPAM/AA@SiO2 particles exhibited pH-responsive characteristics and higher release efficiency compared with mesoporous silica nanoparticles. Moreover, in vitro cell culture experiments demonstrated that the composite particles exhibited better biocompatibility and lower cytotoxic properties. The DOX release profiles and a schematic diagram of the mechanism of drug loading and release of the DOX@PNiPAM/AA@SiO2 nanoparticles are shown in Figure 1. Li et al. designed double-walled silica/polymer nanotubes composed of a silica inner wall and a stimuliresponsive polymeric outer wall as a novel drug carrier. The hybrid nanotubes loaded with active molecules exhibited morphology-dependent release and pH-, temperature-, and redox-responsive release, enabling a wide range of applications, from energy storage to drug delivery and selfhealing coatings for metal corrosion protection.53\n6 J. Biomed. Nanotechnol. 12, 1–27, 2016\nDelivered by Publishing Technology to: Rice University IP: 208.98.249.39 On: Wed, 23 Dec 2015 17:22:25\nCopyright: American Scientific Publishers\nPhotoresponsive drug delivery systems have received increased attention due to their advantages in the spatial and temporal control of drug release, particularly for phototherapy applications. Mesoporous silica nanoparticles functionalized with azobenzene have attracted great attention due to the photoactive responses of the composite materials. For example, Lu et al. have designed light-responsive mesoporous silica nanoparticles with azobenzene derivatives as both impellers and gatekeepers. The drug release properties could be manipulated by varying both the light intensity and irradiation time, resulting in the potential to trap and release useful molecules on demand.54 Other mesoporous-silica-based photoirradiation-responsive controlled drug delivery systems have also been reported, such as nitroveratrylmodified mesoporous silica nanoparticles55 and spiropyran photochrome-modified mesoporous silica materials.56"
    }, {
      "heading" : "QD-BASED NANOSTRUCTURES FOR DRUG DELIVERY SYSTEMS",
      "text" : "QDs are light-emitting nanocrystals ranging from 2 to 10 nm in diameter composed of semiconductor materials, including II–VI (e.g., CdSe, ZnS), IV–VI (e.g., PbSe, PbS) or III–V (e.g., InP, GaAs, GaN) materials as well as\nAu@CdSe, FePt@CdSe, CdTeSe, CdHgTe, CdHgTe/ZnS, ZnTe/CdSe, PbS, and Mn:ZnS.57–59 These QDs exhibit advantageous fluorescence properties for biological and chemical applications due to their unique quantum size effect, confinement effect, and optical and electronic properties.60–63\nDue to their various advanced fluorescence properties, such as improved signal brightness, size-tunable fluorescence properties with high quantum yield and resistance to photo bleaching, QDs are widely used as probes in imaging or labeling both in vitro and in vivo.64–70 The success of QDs in biological imaging, sensing and detection has encouraged scientists to further develop QD-based technology for clinical and translational research. One emerging application is to combine QDs with drug delivery systems because QDs have the potential to elucidate the pharmacokinetics and pharmacodynamics of drug candidates, thus facilitating in-depth studies of nanoscale drug delivery systems through real-time monitoring of nanoparticle bio-distribution, intracellular uptake, drug release and long-term nanocarrier fate.69 In summary, nanocarriers that include QDs can be multi-functional, enabling the incorporation of drugs, affinity ligands, and imaging moieties within a single nanoparticle vector to achieve targeted and\nJ. Biomed. Nanotechnol. 12, 1–27, 2016 7\nDelivered by Publishing Technology to: Rice University IP: 208.98.249.39 On: Wed, 23 Dec 2015 17:22:25\nCopyright: American Scientific Publishers\ntraceable drug delivery. Appropriate preparation methods and modification will enhance the biocompatibility of QDs and make them promising candidates as nanocarriers in biological systems and for in vivo applications.71–74\nThere are two approaches for the integration of QDs and drugs into a single nanoparticle formulation. One is to conjugate or link drug molecules to the QD surfaces and then deliver the drug-conjugated QDs to specific sites. The other method is to load the drug in liposomes or polymer nanoparticle systems that also contain either hydrophobic or hydrophilic QDs, in which the QDs act as tags for the drug delivery vehicle.75 Here, we review QD-based nanocarriers in biological applications, particularly in the anti-cancer field."
    }, {
      "heading" : "QDs as Drug Delivery Vehicles",
      "text" : "QDs possess high surface-to-volume ratios and are easily modified with multiple functionalities. Combining QDs and therapeutic agents in a single construct can improve therapeutic effects. QDs have been engineered to carry different classes\nof therapeutic agents for simultaneous imaging and therapeutic applications. Reports have described the conjugation of small drug molecules or macromolecules such as peptides and DNA to QDs. The formulation of QDdrug conjugates would facilitate the elucidation of the mechanistic pathways of drug delivery as well as the diagnosis and treatment of many diseases. Manabe et al. conjugated QDs to captopril (QD-cap). By measuring the fluorescence intensity of the QDs, they analyzed the QDcap concentration in the blood and the small-molecule dynamics and kinetics, which revealed that QD-caps had approximately the same half-life as captopril. In addition, the QD fluorescence revealed that the QD-caps accumulated in the liver, lungs, and spleen.76 Byrne’s group prepared thioglycolic-acid-stabilized CdTe QDs (TGAstabilized QDs) and demonstrated that these QDs can traverse the THP-1 macrophage cell membrane, illuminate the cytoplasm and decorate the nuclear membrane. The ability to traverse the cell membrane of macrophages is a formidable quality with potential applications in imaging and therapeutics. More importantly, a range of potential applications, from drug delivery to the examination of intracellular processes in living cells, could be realized by such QD delivery systems.77\nBiological molecules have also been used to functionalize QDs. Bagalkot et al. functionalized the surfaces of CdSe/ZnS core–shell fluorescent QDs with the A10 RNA aptamer and then intercalated DOX to form a QD-aptamer(DOX) conjugate for targeted cancer imaging, therapy, and sensing in vitro based on a Bi-FRET mechanism (Fig. 2(A)). First, in the formation of the QDaptamer(DOX), the fluorescence of both the QDs and of DOX was quenched through a Bi-FRET mechanism. After the QD-aptamer(DOX) conjugates were endocytosed into\nthe targeted cancer cells, DOX was released from the conjugates, and fluorescence was recovered from both the QDs and DOX. This feature will enable targeted intracellular delivery of DOX and monitoring of cancer cell killing.78\nIn addition to their applications in small-molecule delivery and fluorescence localization, QDs also have great potential as siRNA delivery systems.79–82 Indeed, QDtagged delivery systems have been reported in the areas of oligodeoxynucleotide (ODN) and siRNA delivery.83–87\nQi and Gao prepared a new multifunctional, compact, traceable nanocarrier by combining semiconductor QDs and amphipols together to enable efficient delivery and real-time imaging of siRNA in live cells. Compared with classic siRNA carriers such as Lipofectamine and polyethyleneimine (PEI), the nanocarrier functioned in both serum-free and complete cell culture media. It also outperformed PEI in gene silencing with significantly reduced toxicity.88 The same authors also developed proton-absorbing polymeric-coated (proton sponges) QD multifunctional nanoparticles. With a balanced composition of tertiary amine and carboxylic acid groups, these nanoparticles were specifically designed to address longstanding limitations in siRNA delivery, such as cellular penetration, endosomal release, carrier unpacking, and intracellular transport. More importantly, the nanoparticles achieved a 10–20-fold improvement in gene silencing efficiency and a 5–6-fold reduction in cellular toxicity.89\nChen and co-workers combined unmodified siRNA with QDs as mult colo biological probes to monitor siRNA delivery. Their novel method aimed to tackle common problems such as variations in transfection efficiency, delivery-induced cytotoxicity and ‘off target’ effects at high siRNA concentrations.84 Derfus et al. used a PEGylated QD core as a scaffold and conjugated siRNA and tumor-homing peptides (F3) to the functional groups on the particle surface. This siRNA delivery system exhibited improved silencing efficiency compared with traditional siRNA systems. The delivery of these F3/siRNA-QDs to EGFP-transfected HeLa cells and their release from endosomal entrapment led to significant knockdown of the EGFP signal.90\nIn general, water-dispersible QDs can be functionalized with targeting ligands, crosslinkers for small drug molecules and biomolecules such as siRNA either by direct synthesis methods or by modifying the surface with carboxylic acids, primary amines, and thiols, enabling the use of these QDs as both drug carriers and drug reporters."
    }, {
      "heading" : "QDs as Tags for Other Drug Delivery Vehicles",
      "text" : "Another important application of QDs in drug delivery systems is as labels for conventional drug carriers to create photostable fluorescent reporters. Compared with radioactive tags or organic fluorophores such as fluorescein or cyanine dyes, QDs are superior because of their unique spectral properties, such as high signal brightness,\n8 J. Biomed. Nanotechnol. 12, 1–27, 2016\nDelivered by Publishing Technology to: Rice University IP: 208.98.249.39 On: Wed, 23 Dec 2015 17:22:25\nCopyright: American Scientific Publishers\nsize-tunable light emission, and photobleaching resistance. Furthermore, QDs can be tuned to a variety of precise wavelengths from UV to NIR. Several QDs, such as CdHgTe and CdTeSe/CdS QDs, can be engineered with wavelengths in the range of 700–900 nm, which is the “transparent window” of biological species, effectively eliminating light absorbance and background interference from tissues and body fluids.\nQDs have recently been engineered as tags for large drug carriers, such as liposomes,91–93 polymeric nanoparticles, chitosan,94 and carbon nanotubes.95 Weng et al. prepared QD-conjugated immunoliposome-based nanoparticles and inserted scFv or loaded DOX. The pharmacokinetic properties and in vivo imaging capability of the conjugates were then investigated.91 Al-Jamal et al. engineered various types of hybrid vesicles consisting of functionalized (PEG-lipid coated) QDs encapsulated into\nthe aqueous core of a variety of liposomes (f-QD-L) for the simultaneous delivery of therapeutic and diagnostic agents in vivo for systemic solid tumor targeting and labeling.93 96\nCho et al. developed a multifunctional nanocarrier system by conjugating QDs to magnetic nanospheres (MNSs) and incorporating PTX into the fluorescent nanocarrier using a layer of biodegradable PLGA (PTX-PLGA-QD-MNSs) (Fig. 2(B)). Cellular uptake could be effectively tracked by the QD fluorescence.80 Tan et al. first presented a novel and easy method of encapsulating QDs into chitosan nanoparticle drug carriers (Fig. 2(C)). They successfully synthesized multicolored QD-labeled chitosan nanoparticles and QD-Gd-DTPA-embedded fluorescent-magnetic dual functional chitosan nanoparticles. Furthermore, they used this hybrid material to deliver HER2/neu siRNA. Using this construct, the delivery and transfection of the siRNA could be monitored by the presence of fluorescent\nJ. Biomed. Nanotechnol. 12, 1–27, 2016 9\nDelivered by Publishing Technology to: Rice University IP: 208.98.249.39 On: Wed, 23 Dec 2015 17:22:25\nCopyright: American Scientific Publishers\nQDs in the chitosan nanoparticles. The targeted delivery of HER2 siRNA to HER2-overexpressing SKBR3 breast cancer cells was shown to be specific using chitosan/QD NP surfaces labeled with HER2 antibodies that targeted the HER2 receptors on SKBR3 cells. These self-tracking siRNA delivery nanoparticles will also facilitate monitoring in future in vivo gene silencing studies.94 97\nCarbon nanotubes have also emerged as a new alternative and efficient tool for transporting and translocating therapeutic molecules. The preparation of novel fluorescent nanoparticles by integrating carbon nanotubes and QDs has attracted considerable attention. Jia et al. explored a novel, double functionalized carbon nanotube delivery system in which CdTe QDs were added to enable fluorescent labeling via electrostatic layer-by-layer assembly. Antisense oligodeoxynucleotides (ASODNs) were loaded as the therapeutic gene. This system satisfied the goal of developing an improved delivery scheme for intracellular tracking and anticancer therapy.86 Guo et al. directly conjugated amino-functionalized CdSe/ZnS QDs to the surfaces of multi-walled nanotubes through amide linkages and studied the in vivo distribution behavior of the complex. Furthermore, they selected NIR CdSeTe/ZnS QDs with long emission wavelengths of 752 nm and incorporated the antitumor drug paclitaxel into the carbon nanotubes (Fig. 2(D)). The novel nanostructure exhibited high loading efficiency for paclitaxel and strong luminescence upon intravenous injection and in vivo imaging in live mice. Figure 2(E) shows the bright fluorescence observed after the six-day circulation of the CNT-QDs; strong fluorescence was observed in the liver, kidneys, stomach and intestine, indicating that the multi-walled nanotube nanocarriers mainly accumulated in these organs.95\nAlthough QDs have become increasingly attractive in drug delivery and tagging due to their unique properties, such as small size and easily modified surfaces, some problems remain. First, most QDs contain heavy metals, such as Cd, Pb, and Hg. The serious intrinsic toxicity and potential environmental hazards associated with heavy metals have limited the applications of QDs in vivo. Therefore, studies are needed to develop an environmentally friendly synthesis method and explore the biocompatible modification of QDs.71–74 Second, achieving controllable drug release by modifying QDs with pH-, light-, temperature- or ultrasound-sensitive functional groups is of great significance in the design of nanocarriers that can combine imaging, targeting, and therapy into a single unit."
    }, {
      "heading" : "CARBON-BASED NANOSTRUCTURES FOR DRUG DELIVERY SYSTEMS",
      "text" : "Since the discovery of C60 in 1985, carbon-based nanomaterials have gradually entered a new era. The properties of nanosized carbon structures\nare dramatically different from their macroscopic\ncounterparts.98–102 Carbon-based nanomaterials with diverse morphologies and microstructures, including carbon nanoparticles,103 104 fullerenes,98 105 graphene,101 carbon nanobubes,99 100 diamonds,106 and other various carbon-based hybrid nanostructures, have been prepared and investigated. They have recently attracted increased attention due to several advantages, including their high resistance due to their compact structure or stiffness; their large surface area, which can be further modified by drugs or targeting molecules; and their small dimensions, which facilitate entry into narrow cellular compartments. Overall, carbon-based nanomaterials have shown great promise for drug delivery purposes."
    }, {
      "heading" : "Carbon Nanoparticles",
      "text" : "Carbon nanoparticles are amorphous species composed of sp2-hybridized carbon without crystalline structural components. The dimensions of carbon nanoparticles usually range from approximately 5 nm to 50 nm, which is very close to the size of proteins in cells and tissues, facilitating uptake of this type of nanoparticle by cells.107 108 Cells growing in tissue culture uptake most of these nanoparticles, suggesting that these nanoparticles might have potential as nanoscale drug delivery systems. The pharmacokinetic profiles of such drug nanocarriers are largely affected by splenic filtration, which takes place at the inter-endothelial cell slits in the walls of the venous sinuses.109 Hollow carbon nanoparticles show promise as drug delivery systems due to their desirable chemical and physical properties, such as high surface areas and excellent flow performances.26 This type of drug carrier exhibits controlled drug release and targeting, meeting the demands of modern diagnosis and therapy. Mesoporous carbon nanoparticles, also known as hollow carbon dots, are a successful example of hollow carbon-based nanomaterials with defined pore morphologies.110\nHollow carbon dots were recently used as a delivery system for DOX.111 The DOX-hollow carbon dot drug delivery systems exhibited pH-controlled release and rapid uptake by cells. The DOX-hollow carbon dot solutions were stable for several weeks without aggregation and emitted red fluorescence under UV irradiation (Fig. 3(A)). In addition, the cellular uptake and intracellular trafficking mechanisms of the DOX-hollow carbon dots were determined. The DOX-hollow carbon dots entered the cells by endocytosis with vesicle formation, and the DOX-hollow carbon dot vesicles were then transported into the lysosomes. Finally, in the acidic environment of the lysosomes, protonated DOX was released and entered the nucleus (Fig. 3(B))."
    }, {
      "heading" : "Fullerenes",
      "text" : "Fullerenes, also called Buckminsterfullerenes or C60, are truncated icosahedrons containing 60 carbon atoms with C5–C5 single bonds forming pentagons and C5–C6 double\n10 J. Biomed. Nanotechnol. 12, 1–27, 2016\nDelivered by Publishing Technology to: Rice University IP: 208.98.249.39 On: Wed, 23 Dec 2015 17:22:25\nCopyright: American Scientific Publishers\nbonds forming hexagons.98 Fullerenes can carry drugs or genes attached by hydrophilic chains or groups.112 113\nDerivatized fullerenes can cross the cell membrane and bind to mitochondria.112 Several groups have investigated the synthesis of appropriate fullerene derivatives for intracellular drug delivery.114 Zakharian et al. reported that a fullerene-based system enabled the slow release of the anticancer drug paclitaxel.115 Fullerene and paclitaxel were chemically functionalized to incorporate a cleavable ester bond between them. The anticancer activity of the paclitaxel conjugate was activated upon release from fullerene by cleavage of the ester linkage. DOX was attached to fullerene using a similar approach. DOX itself is sparingly soluble in water, and conjugation to fullerene increased its solubility due to the presence of two PEG chains, thereby increasing the bioavailability of DOX.116\nThe usual administration route of erythropoietin is intravenous injection because its biological activity is dramatically reduced by degradation by enzymes in the intestine upon oral administration. A pharmacokinetic analysis revealed that conjugation of erythropoietin to fullerene greatly improved erythropoietin bioavailability by nearly threefold compared to intraperitoneal administration.117\nMoreover, fullerenes functionalized with DNA exhibit superior efficiency compared to commercially available lipid-based vectors.118 In the first in vivo gene delivery experiment with fullerene derivatives, cationic tetra aminofullerene, which has high water-solubility, was used to complex DNA, and its efficiency and toxicity were compared to those of Lipofectin.119 No acute toxicity was reported for the fullerene complex compared to Lipofectin administration."
    }, {
      "heading" : "Graphene",
      "text" : "Graphene is a type of two-dimensional graphitic carbon system that is one atom thick. Due to their large surface areas and delocalized p-orbital electrons, graphene derivatives can solubilize and bind drug molecules and thus have the potential to be used as drug delivery vehicles if sufficiently high drug loading and suitable in vivo drug distribution and release profiles can be achieved. Graphene is also lipophilic, which might be relevant to addressing another challenge in drug delivery: membrane barrier penetration.120\nGraphene oxide is obtained after treating graphite with fuming nitric acid and potassium chlorate. Graphene oxide is a promising material for biological applications due to its large specific surface area. Ultra-small nano-graphene oxide has been reported by Sun and co-workers.121 This system has dimensions of less than 10 nm, and covalent modification with PEG chains ensured water dispersibility. The nano-graphene oxide sheets displayed photoluminescence ranging from the visible to the NIR, thus enabling cellular imaging, and the aromatic anticancer drug DOX was loaded via simple physical adsorption. Nano-graphene oxide exhibited superior drug adsorption compared to other carbon-based materials used for drug adsorption via -stacking.122"
    }, {
      "heading" : "Carbon Nanotubes",
      "text" : "Carbon nanotubes possess several ideal properties for drug delivery.123 For in vitro drug delivery systems, small drug molecules can be covalently conjugated to carbon nanotubes. Fluorescent dyes and drug molecules have been synchronously linked to carbon nanotubes to deliver antifungal drugs.124 Targeting ligands, including folic acid (FA),125 peptides,126 and antibodies,127 128 have been used to target carbon nanotubes to different types of cells or tumors. In a recent report, Dhar et al. linked FA to a Pt prodrug, then conjugated the construct to PEGylated single-walled nanotubes,125 creating a single-walled nanotube-Pt-FA conjugate. This targeted delivery produced toxicity in folate receptor-positive cells but not negative cells. In another study of the delivery of DOX using singlewalled nanotubes, targeting molecules such as arginineglycine-aspartic acid peptide (RGD) were conjugated for targeting.122\nFor gene transfection, carbon nanotubes can be modified with positive charges to enable DNA binding. Pantarotto et al. and Singh et al. reported that single-walled nanotubes and multi-walled nanotubes functionalized via 1,3- dipolar cycloaddition achieved appropriate transfection efficiency.129 Liu et al. reported the use of MWNTs grafted with PEI for DNA delivery, which afforded comparable efficacy.130\nJ. Biomed. Nanotechnol. 12, 1–27, 2016 11\nDelivered by Publishing Technology to: Rice University IP: 208.98.249.39 On: Wed, 23 Dec 2015 17:22:25\nCopyright: American Scientific Publishers"
    }, {
      "heading" : "Diamonds",
      "text" : "Nanodiamonds are typically defined as diamond particles that are less than 100 nm in size. Nanodiamonds possess most of the properties required for a drug delivery platform, including scalability, biocompatibility, dispersibility in water, the ability to carry a broad range of therapeutics, and the potential for targeted therapy.131–133 Initial studies have demonstrated that nanodiamonds can mediate the delivery of DOX.134 The efficacy and safety of nanodiamonds were recently validated in mice; nanodiamonds reduced the capacity of tumors to expel DOX (Fig. 4(A)), and the circulation half-life of the nanodiamond-DOX complexes was approximately 10 times longer than that of unmodified DOX. The extended release of the drug from the nanodiamond-DOX conjugates yielded a steady, lethal dose of drug in the cell, in contrast to free DOX.135 Due to their resistance to chemotherapy, tumors treated with DOX or PBS exhibited only limited size reductions, while tumors treated with nanodiamond-DOX exhibited significant size reductions (Fig. 4(B)).136\nIn addition to delivering small molecules, nanodiamonds have been used to deliver nucleic acids after coating of the nanodiamonds with polyethylenimine 800 (PEI800).133\nNanodiamond-PEI800-mediated delivery of siRNA to silence GFP expression yielded increased efficacy compared to Lipofectamine under physiological conditions.137\nA variety of other cargos have been delivered by nanodiamonds, including covalently attached drugs,138 proteins,139\nsmall molecules under acidic conditions (which are\ncommonly observed in tumors) and siRNA for specific cancers.131 Nanodiamonds have been used not only as potential injectable therapeutic agents for generalized drug delivery but also in films of parylene-nanodiamond composites to enable localized sustained release of drugs over periods ranging from two days to one month.140 141\nThe above sections have briefly summarized progress in the use of carbon-based nanomaterials in drug delivery over the last decade, with an emphasis on carbon nanoparticles, fullerenes, graphene, carbon nanotubes and diamonds. These nanomaterials can be either covalently or non-covalently modified to increase their biocompatibility. Carbon-based nanostructured delivery architectures are promising candidates for the efficient and targeted delivery of novel drug compounds."
    }, {
      "heading" : "GOLD NANOSTRUCTURES AS DRUG DELIVERY SYSTEMS",
      "text" : "The use of gold in biomedical fields dates to 2500–2600 BC. Gold-based compounds have recently been employed in clinical applications. The multiple roles of gold nanostructures in many biomedical fields as biosensors142 and for imaging,143 photodynamic therapy/photothermal therapy,144 and drug delivery145–147 have been extensively described (Fig. 5). Gold nanostructures are attractive as drug carriers due to their non-tox and non-immunogenic properties,148 facile synthesis in a variety of shapes,146 149 150 and ease of surface modification.151 In addition, the unique optical properties of gold nanostructures, as determined by localized surface plasmon resonance (LSPR), are highly shapeand size-dependent, with many potential applications in biomedical fields.146 In this section, we will discuss the applications of gold nanostructures of different shapes in drug delivery."
    }, {
      "heading" : "Gold Nanospheres",
      "text" : "Gold nanostructures can be divided into several subtypes based on their shape and physical properties. Among these subtypes, the spherical nanostructure is one of the simplest forms of gold nanostructures. Gold nanospheres have received considerable attention since the successful synthesis of gold nanospheres was first described in 1951 by Turkevich.152 The particle sizes of the most commonly used gold nanospheres range from a few nanometers to approximately 100 nanometers, with absorption wavelengths ranging from 500 to 600 nm; the maximum absorption wavelength of gold nanospheres increases as its diameter increases. In the initial application of gold nanospheres as drug\ndelivery systems, the payloads attached to the gold nanospheres often relied on Au-thiol bonds. Although simply attaching a thiol moiety to the ligand of choice is sufficient to permit functionalization of gold nanospheres, a single thiol group bound to the gold surface has some\n12 J. Biomed. Nanotechnol. 12, 1–27, 2016\nDelivered by Publishing Technology to: Rice University IP: 208.98.249.39 On: Wed, 23 Dec 2015 17:22:25\nCopyright: American Scientific Publishers\nlimitations.153 Hong et al. reported that intracellular glutathione (GSH) can displace the thiol monolayer on gold nanospheres, thus releasing the therapeutic cargo covalently bound to the monolayer154 and resulting in unwanted payload release. Thus, new strategies are needed to achieve higher stability in drug delivery systems. Multiple thiols, such as cyclical disulfide,155 thioctic acid,156 and dithiocarbamate,157 have been intensively studied for grafting to gold nanospheres to provide increased chemical stability. These binding motifs provide stronger binding than the traditional gold-thiol bond and can be used in situations in which increased strength is required. Many studies have demonstrated the successful attachment of therapeutic agents to gold nanospheres. For example, naked gold nanospheres were functionalized with a thiolated PEG monolayer capped with a carboxylate group, followed by attachment of oxaliplatin to the surface of the PEG to form a complex drug delivery system with 280±20 drug molecules per nanoparticle. In vitro studies demonstrated that these nanovehicles effectively improved drug delivery efficacy.158\nNanoparticle delivery systems can be classified as passive or active targets. In earlier studies, gold-based drug delivery systems for cancer therapy relied on a passive targeting effect to direct nanocarriers to tumor sites.159\nGold nanospheres can be easily modified with ligands to confer specific functionalities and consequently also easily adsorb proteins or other biomacromolecules.160 Nonspecific absorption can affect the surface properties of gold nanostructures and their cellular uptake properties.161\nTherefore, for in vivo applications, most gold nanostructures are conjugated with organic polymers to prevent particle aggregation, nonspecific protein adsorption, and the uptake of circulating gold nanostructures by the reticuloendothelial system, prolonging circulation in the blood\nstream and increasing the accumulation of gold nanostructures in tumors through passive targeting.162 However, due to the different degrees of vascularization and porosity in tumor vessels, targeting cancer cells by the EPR effect is not feasible in all tumors, limiting passive targeting approaches. One means of overcoming this limitation is to attach targeting molecules to the drug carrier surface, known as act v targeting. Liang et al. synthesized small (2 nm) gold nanoparticles. To enable their use in therapy, the gold nanoparticles were functionalized with therapeutic peptides (PMI) and targeting peptides (CRGDK). In vitro studies demonstrated that this nanosystem significantly improved uptake by MDA-MB-321 cells due to receptor-mediated recognition and internalization, and the therapeutic peptides were also significantly absorbed by the cancer cells. Consequently, this nanosystem exhibited strong in vitro anti-cancer activity. These results indicate that functionalized gold nanoparticles could be a promising anticancer drug for improving the efficacy of therapeutic molecules.163\nPassive and active targeting can result in the accumulation of gold nanospheres in diseased tissues. Various stimuli can then be used to trigger drug release. These stimuli include intracellular GSH changes, pH changes, light, and heat. Thus, it is possible to create drug delivery systems that not only deliver payloads to a specific site but also enable controlled drug release by an outside stimulus. Most gold-based drug delivery systems rely on disul-\nfide linkages between the drugs and carriers. Intracellular GSH can be used to release payloads on gold nanospheres through either place-exchange reactions at the core or via disulfide exchange. In early studies, Hong et al. developed a gold nanosphere-based delivery system featuring GSH release.154 They linked a hydrophobic dye (HSBDP) to gold nanospheres as a model drug. In this nanosystem, the HSDBP ligand was non-fluorescent when attached to\nJ. Biomed. Nanotechnol. 12, 1–27, 2016 13\nDelivered by Publishing Technology to: Rice University IP: 208.98.249.39 On: Wed, 23 Dec 2015 17:22:25\nCopyright: American Scientific Publishers\nthe gold nanospheres due to fluorescence quenching by the gold core; fluorescence was triggered by release of the HSDBP ligand by intracellular GSH (Fig. 6(A)). In a similar fashion, the intracellular GSH level could also regulate the transfection efficiency of the DNA attached to the gold nanospheres.164\nDrugs can also be attached to gold nanospheres through switchable bonds. Payload drugs lose their activity upon covalent linkage, and their activity is restored upon photoirradiation. Vivero-Escoto and coworkers have developed a composite nanostructure comprising gold-nanospherecapped mesoporous silica nanoparticles for the photoinduced controlled release of paclitaxel. The mesopores of the mesoporous silica nanoparticles were efficiently capped with gold nanospheres to prevent paclitaxel leakage. Upon photo irradiation, the photocleavable linker covalently attached to the gold nanospheres was cleaved, resulting in drug release (Fig. 6(B)).165 Due to their interactions with light, gold nanostructures can convert irradiation to local heat, making them suitable for optically responsive smart drug delivery. Gold nanospheres (∼60 nm in diameter) coated with a thermally responsive biocompatible hydrogel overlay can be tailored to exhibit a lower critical solution temperature (LCST) slightly higher than physiological temperature. This hybrid nanostructure can be activated by exposure to light at wavelengths that can be absorbed by the plasmon resonance of the gold nanosphere cores (Fig. 6(C)).166\npH-triggered drug release is another important stimuli response mechanism. Prabaharan et al. recently reported the synthesis of FA-conjugated amphiphilic gold nanospheres as anticancer drug delivery systems. DOX was covalently conjugated to the hydrophobic inner shell via an acid-cleavable hydrazone linkage. The release rates of conjugated DOX were greater at pH 5.3 and 6.6 than at pH 7.4, indicating that the gold nanosphere-DOX conjugate is a promising pH-triggered system for drug delivery (Fig. 6(D)).167\nGold nanoshells are another type of spherical gold nanostructure. Compared with solid nanospheres, gold nanoshells exhibit optical resonances that can be adjusted to nearly any wavelength within the optical and infrared spectrum,168 increasing their suitability for biological applications. Nanoshells absorb strongly in the NIR, making them useful as local heat sources for hyperthermiabased tumor ablation and drug delivery.169 Hybrid structures that combine gold nanoshells and other functional inorganic nanoparticles into a single unit have very promising applications in drug delivery.170 Recently, Ma et al. developed a hybrid nanostructure comprising a gold nanoshell coated with cholesterylsuccinyl silane molecules and loaded with both DOX and Fe3O4 magnetic nanoparticles. These systems have a variety of functions, such as MR imaging, magnetic-field-guided drug delivery, light-triggered drug release, and photothermal therapy.169\n14 J. Biomed. Nanotechnol. 12, 1–27, 2016\nDelivered by Publishing Technology to: Rice University IP: 208.98.249.39 On: Wed, 23 Dec 2015 17:22:25\nCopyright: American Scientific Publishers"
    }, {
      "heading" : "Gold Nanorods",
      "text" : "Non-spherical nanoparticles have some potential advantages over spherical nanoparticles as a versatile delivery system; gold nanorods may be a particularly promising choice. Gold nanorods and their anisotropic optical properties have attracted attention since Foss and co-workers first introduced the template method for the preparation of gold nanorods in 1992.171 Compared with conventional spherical nanoparticles, gold nanorods have shown greater potential in biomedical applications.154 One great virtue of gold nanorods is that they possess stronger size-normalized absorption cross-sections than common gold nanospheres. Gold nanorods can either scatter or absorb light. The scattered photons can be used for imaging applications, while the absorbed photons can be utilized for photothermal effects.172 The photothermal properties of gold nanorods has been successfully exploited in photothermal therapy to remove solid tumors and have applications in drug delivery for controlling drug release.173 When gold nanorods are capped with a temperature-sensitive polymer, the NIRirradiated gold nanorods deliver localized heat to the polymeric matrix or shell, inducing a phase transition in the polymeric matrix chains. Such NIR-active nanostructures have shown tremendous potential in controlledrelease drug delivery. The generated heat can also be used to increase drug efficacy. In particular, the combined effects of heat on chemotherapeutic agents can synergistically improve the efficacy of drug delivery.174 Wei et al. synthesized a NIR-responsive nanohybrid by the surface-initiated atom transfer radical polymerization of PNiPAAm on gold nanorods. The nanohybrids were both temperature- and NIR light-sensitive. The temperatureresponsive range of gold nanorods/PNiPAAm is 32–37 C, and the polymer shells can be loaded with norvancomycin molecules via hydrogen bonding interactions; furthermore, NIR-responsive release behavior has been demonstrated.175\nIn addition, in contrast to gold nanospheres, gold nanorods exhibit two LSPR bands—the longitudinal and transverse resonance bands—with extinction maxima at 520 nm for the short axis and in the visible or NIR range for the long axis. By controlling the aspect ratio (ratio of length to diameter), the LSPR maximum can be easily shifted to the NIR region.172 Therefore, gold nanorods can potentially be used as contrast agents for bioimaging using NIR light or as heating devices for hyperthermia and drug delivery systems. Because the LSPR band can be tuned by changing the gold nanorod aspect ratio, gold nanorods with different aspect ratios can be detected independently at different wavelengths. Conjugation of different gold nanorods to different molecules could permit the orthogonal triggered release of multiple species. Wijaya et al. loaded two different DNA oligonucleotides (FAMDNA and TMR DNA) onto two different gold nanorods via thiol conjugation. Then, selective release was induced by the selective melting of gold nanorods via ultrafast laser\nirradiation at the nanorods’ LSPR peaks. A specific wavelength of laser excitation can selectively melt one type of gold nanorod, thereby selectively releasing only one type of DNA strand. Their results demonstrated efficient release that was externally tunable by laser frequency. This concept is a potentially powerful method for multiple-drug delivery strategies.176\nThe unique optical properties of gold nanorods permit the development of multifunctional drug delivery systems. Xiao et al. developed a gold-nanorod-based nanoplatform for targeted anticancer transport and positron emission tomography (PET) imaging of tumors. In this nanoplatform, DOX was covalently conjugated to PEG-ylated gold nanorods by a hydrazone linkage to achieve pH-sensitive controlled drug release. To achieve both tumor targeting and PET imaging, tumor-targeting ligands (RGD) and 64Cu-chelators were subsequently attached to the distal ends of the PEG. This novel nanoplatform possessed multifunctional moieties, enabling molecular targeting, chemotherapy, photothermal therapy and multimodal PET/optical imaging and potentially improved therapeutic efficacy and cancer monitoring.177 Venkatesan et al. have also developed a multifunctional nanosystem for the delivery of DOX to tumor tissues. In this system, gold nanorods and DOX were conjugated with improved drug loading efficiency (55± 6%) and minimal CTAB toxicity by employing gold nanorods (4 4± 0 5 aspect ratio) coated with poly(sodium 4-styrenesulfonate). This system exhib ted higher biological stability with sustained drug release kinetics at pH 5, and the binding of DOX molecules to the poly(sodium 4-styrenesulfonate)coated gold nanorods (poly(sodium 4-styrenesulfonate)gold nanorods) was monitored by fluorescence quenching and LSPR signals. In vitro studies indicated that the anti-cancer potential and apoptosis-inducing efficiency of the DOX@poly(sodium 4-styrenesulfonate)-gold nanorod conjugates in MCF-7 cells resulted in higher therapeutic efficiency compared with free DOX. Thus, the DOX@poly(sodium 4-styrenesulfonate)-gold nanorod conjugates demonstrated significant therapeutic potential, indicating their potential for use in anticancer therapy.178"
    }, {
      "heading" : "Gold Nanocages",
      "text" : "Gold nanocages represent a novel class of nanostructures first developed by Sun et al. in 2002.179 They possess a hollow interior, porous walls, and roughly cubic geometry. The most important characteristics of gold nanocages are their adjustable optical properties. The LSPR peaks of gold nanocages can be tuned to any wavelength in the visible to NIR region by controlling the size and wall thickness of the gold nanocages.180\nFor in vivo therapeutic applications, the size, shape and surface properties of gold nanocages must be engineered to optimize their targeting efficacy and uptake by the desired biological system. As with other gold\nJ. Biomed. Nanotechnol. 12, 1–27, 2016 15\nDelivered by Publishing Technology to: Rice University IP: 208.98.249.39 On: Wed, 23 Dec 2015 17:22:25\nCopyright: American Scientific Publishers\nnanostructures, nanocages can also be easily modified by thiol-terminated compounds. For instance, sigma-2 receptors have been observed in a diverse set of human and rodent tumor cells,181 and the level of sigma-2 receptors in proliferating tumor cells is 10-fold higher than that in quiescent tumor cells,182 making them candidates for targeted therapy. Wang et al. conjugated a small, synthetic molecule specific to sigma-2 receptors (SV119) to gold nanocages. In vitro studies indicated that the functional gold nanocages effectively targeted different types of cancer cells.183 The ability of gold nanocages to load chemotherapeutic drugs, their photothermal effects and their imaging capabilities indicate the potential suitability of this multifunctional system for cancer treatment. Furthermore, unlike nanorods and nanoshells, these hol-\nlow, porous gold nanocage structures can store drugs in their interiors rather than simply on their surfaces. Due to their hollow interiors, porous walls, and tunable LSPR properties, gold nanocages can be used for controlled drug release. Yavuz et al. functionalized the surfaces of nanocages with thermally responsive polymers to control drug release with NIR laser irradiation or high-intensity focused ultrasound (HIFU).184 In this system, PNiPAAm was grafted onto the surfaces of the nanocages through thiolate linkages. These polymers can change conformation in response to small variations in temperature at a threshold known as the LCST.185 When the modified gold nanocages were exposed to a laser beam with a wavelength matching the LSPR peak of the nanocages, the light was absorbed and converted into heat. The increase in temperature induced by heat dissipation caused the polymer chains to collapse, thus exposing the pores in the nanocages and resulting in the release of the pre-loaded effectors. Once the laser was turned off, the heating ceased. The polymer then returned to its original state, the pores closed, and drug release stopped. Notably, this system can be used for the release of a variety of compounds, including dyes, drugs, and enzymes. Although significant advances have been made in the\nfield of drug delivery involving gold nanocages, this type of drug carrier still has some shortcomings. For example, the as-prepared nanocages reported previously were typically coated with a hydrophilic polymer, which would make it difficult for a hydrophobic species to diffuse into the hydrophilic interior of the nanocages.186 However, more than 40% of the active compounds identified by combinatorial screening programs are poorly soluble in water.187 Thus, novel systems that are well suited for the encapsulation of both hydrophilic and hydrophobic drugs must be identified. In a recent study, Moon et al. combined a phase change material (PCM) and nanocages to form a smart delivery vehicle that could load either hydrophobic or hydrophilic drugs. In this system, PCM served as a “gatekeeper” to control the release of the drug in response to temperature increases.186 1-Tetradecanol, which has a\nmelting point of 38–39 C, was employed as a PCM. When the PCM was melted at a high temperature and mixed with substances, it entered a liquid state that could easily enter the nanocages. When the temperature was lowered, the PCMs returned to a solid state, and release could then be controlled by varying the power of HIFU or the duration of HIFU exposure. In summary, gold nanostructures have emerged as a\npromising material for drug delivery and provide a useful supplement to traditional drug delivery systems. The combination of tunable morphology, optical properties, low inherent toxicity, and functional versatility imparts novel characteristics and enables new delivery strategies. The greatest remaining challenge is the translation of these techniques to clinical settings.\nMAGNETIC IRON OXIDE-BASED NANOSTRUCTURES FOR DRUG DELIVERY SYSTEMS In the late 1970s, the pioneering concept of using an external magnetic field coupled with magnetic carriers was proposed by Freeman et al.188 A variety of magnetic particle carriers have since been studied to deliver drugs to specific target sites in vivo.189 Magnetic iron oxide nanoparticles (Fe3O4 nanoparticles) can be delivered in a controlled manner to the targeted area through an external magnetic field.190–192 The drugs can be loaded onto functionalized Fe3O4 nanoparticles and delivered to the targeted area. Fe3O4 nanoparticles with core/shell structures have the advantages of good dispersion, high stability, and high drug loading rates and are widely used as sources of magnetic materials. Common surface modification materials for Fe3O4 nanoparticles include inorganic materials, polymers and other coating materials. Coating materials play an important role in the stabilization of aqueous Fe3O4 nanoparticle suspensions as well as their further functionalization. The surface modification of Fe3O4 nanoparticles with various materials can effectively render them water soluble and improve their stability under physiological conditions.193"
    }, {
      "heading" : "Inorganic Material Coating",
      "text" : "Composite nanomaterials with a core/shell structure, e.g., SiO2- and Au-coated Fe3O4 nanoparticles, have attracted considerable attention in recent years. These coating materials prevent not only the chemical degradation of Fe3O4 nanoparticles but also the release of potentially toxic compounds. Fe3O4/SiO2 core/shell nanoparticles with a single core and different shell thicknesses were obtained by a reverse microemulsion method.194 The SiO2 had high porosity characteristics, and the porosity could be adjusted to accommodate loaded drugs of different sizes. This allowed the drugs to be easily embedded into the SiO2\n16 J. Biomed. Nanotechnol. 12, 1–27, 2016\nDelivered by Publishing Technology to: Rice University IP: 208.98.249.39 On: Wed, 23 Dec 2015 17:22:25\nCopyright: American Scientific Publishers\nshells or connected to the surface of the SiO2 nanoparticles. A flexible drug delivery device was fabricated via the electrophoretic deposition of magnetic core/shell Fe3O4/SiO2 nanoparticles onto an electrically conductive flexible polyethylene terephthalate substrate.195 The release of drugs could be controlled by modulating the magnetic field, and the chip exhibited a variety of release profiles (i.e., slow release, sustained release, step-wise release and burst release profiles). A sandwich-structured material (Fe3O4/SiO2/YVO4:Eu\n3+) with mesoporous, magnetic and luminescent properties was synthesized using an improved sol–gel method.41 The multifunctional composite material was a novel, monodisperse, core–shell structured drug storage/release system with spherical silica-coated magnetite as the core and ordered mesoporous silica as the shell, which was further functionalized by the deposition of a phosphor layer. The formation of the Fe3O4/SiO2/YVO4:Eu 3+ microspheres and drug release by this multifunctional system as a function of release time are shown in Figure 7. This composite was an ideal system for targeted drug delivery due to its superparamagnetic characteristics, and drug release could be monitored based on the change in the luminescence intensity of Eu3+ in the drug delivery systems. A nanocomposite consisting of hollow-core-double-shell magnetic iron oxide/silica/calcium silicate was successfully synthesized. The nanocomposite had a drug loading capacity of 75 mg/g, and the drug was completely released within 60 h. The nanocomposite had superparamagnetic behavior and good drug delivery performance, indicating potential applications in targeted drug delivery.196\nMultifunctional nanocomposites synthesized via the dynamic assembly of Fe3O4 and Au nanoparticles might offer many opportunities for targeted cellular imaging and therapy.197 Dumbbell-like Au–Fe3O4 nanoparticles can act as a multifunctional platform for targeted drug delivery. The modification of Au nanoparticles is very useful for linking nanocomposites with diverse biomolecules.\nCompared with conventional single Fe3O4 nanoparticles, dumbbell-like Au–Fe3O4 nanoparticles facilitate the stepwise attachment of an antibody and a drug complex, and the structure can serve as both a magnetic and optical probe for tracking the drug complex in cells and biological systems.198 Wagstaff et al. delivered cisplatin using Aucoated Fe3O4 nanoparticles to improve delivery efficacy to tumors. The nanoparticles could be controlled and moved with an external magnetic field, allowing drug release to be localized to a specific area, which can greatly reduce chemotherapy side effects.199 A multifunctional core–shell structured nanocomposite (Fe3O4/nSiO2/mSiO2/Au) composed of a mesoporous-silica-coated Fe3O4 core and a colloidal Au shell has also been reported.200 The drug release test indicated that the multifunctional system exhibited drug-sustaining properties. This multifunctional nanocomposite can be potentially used as a targeted drug delivery and photothermal therapy system."
    }, {
      "heading" : "Polymer Coating",
      "text" : "Magnetic Fe3O4 nanoparticles coated with polymers are often used in drug delivery. The polymer maintains the stability of the nanoparticles against oxidation, and the drug is released upon biodegradation of the polymer. Drug-loaded magnetic Fe3O4 nanoparticles coated with polymers have many advantages over traditional oral medications, enabling targeted tissue accumulation, extended circulation times and decreased side effects. The ideal polymer for Fe3O4 nanoparticle coatings should have a high affinity for Fe3O4 but low stimulation of the immune system. The most commonly used polymers are glucose, chitosan, dextran, PEG, and starch. The properties of polymer compounds, such as their chemical structure, conformation, molecular weight, size, and length, can affect the overall properties of Fe3O4 nanoparticles. For example, polymers on Fe3O4 nanoparticles can effectively inhibit the aggregation of nanoparticles.\nJ. Biomed. Nanotechnol. 12, 1–27, 2016 17\nDelivered by Publishing Technology to: Rice University IP: 208.98.249.39 On: Wed, 23 Dec 2015 17:22:25\nCopyright: American Scientific Publishers\nGlucose-coated magnetic Fe3O4 nanoparticles exhibited a good loading capacity for aspirin, which was affected by solution pH and temperature. The aspirin was released quickly in the first stage and released slowly in the subsequent stage. These findings will be useful for engineering iron oxide nanoparticles for potential drug delivery carrier applications.201 Fe3O4-PNiPAM composite nanoparticles were synthesized by the dispersion polymerization of n-(isopropylacrylamide) chains in the presence of a magnetite ferrofluid. Given their excellent hyperthermia and drug release behavior, the DOX-loaded thermo-responsive polymer-coated Fe3O4 nanoparticles have the potential to act as agents for the combined targeting, hyperthermia and controlled drug release cancer treatment.202\nA tumor-targeting multifunctional nanocarrier was synthesized using wormlike polymer vesicles by the double emulsion method. These wormlike polymer vesicles were formed by a mixture of two biodegradable triblock copolymers with different terminal groups (Fig. 8). The advantage of using triblock copolymers to form vesicles is that stable vesicles can be formed by crosslinking only the inner hydrophilic PEG layer, thereby greatly minimizing the effect of crosslinking on the vesicles’ drug release rate. The hydrophobic anticancer drug DOX was loaded into the hydrophobic membrane of wormlike polymer vesicles. In addition, a cluster of hydrophilic Fe3O4 nanoparticles was encapsulated into the aqueous core of the stable vesicles with crosslinked inner PEG layers, enabling targeted cancer therapy.203 A multifun - tional tumor-targeting nanosystem carrying both Fe3O4 nanoparticles and DOX was prepared for improved cancer therapy. The DOX-loaded magnetic polymersomes were obtained via the self-assembly of the lipid-containing copolymer poly(acrylic acid-co-distearin acrylate) with citric acid-coated Fe3O4 nanoparticles, followed by DOX encapsulation. Then, chitosan and poly( -glutamic acidco- -glutamyl oxysuccinimide)-g-poly(ethylene glycol)folate were deposited in sequence onto the outer surfaces. The magnetic polymersomes exhibited enhanced pHtunable DOX release and active tumor-targeting ability. When the magnetic polymersomes were effectively internalized by HeLa cells, the combination of pH and magnetic hyperthermia regulation permitted controlled drug release and improved cytotoxicity over DOX alone.204\nThese results demonstrate that multifunctional tumortargeting nanosystems have potential as a new generation of advanced theranostic nanodevices. Core/shell Fe3O4 nanoparticles labeled with organic dye were prepared using modified carboxymethyl chitosan. The thickness of the polymer shell could be easily controlled by adjusting the ratio of magnetic nanoparticles to carboxymethyl chitosan, and the nanoparticles could take up a large amount of therapeutic drug within the shell surfaces. This targeted delivery system may provide a strategy for biological labeling and targeted drug delivery in vivo.205"
    }, {
      "heading" : "Other Material Coatings",
      "text" : "In addition to polymer coatings, other types of organic compounds and biological macromolecules have been used for Fe3O4 nanoparticle functionalization. Tetraheptylammonium-capped Fe3O4 nanoparticles efficiently enhanced DOX accumulation in target cancer, resulting in significantly enhanced DOX uptake in leukemia K562 cells in vitro.206 High entrapment efficiency and sustained release of anticancer drugs can be achieved with glycerol monooleate-coated magnetic nanoparticles. Hydrophobic drugs such as paclitaxel and rapamycin can be partitioned into the glycerol monooleate crust surrounding the iron oxide core. For the conjugation of any peptide or protein, nanoparticles can be functionalized with meso-2,3-mercaptosuccinic acid. The targeted therapeutic purpose of the multifunctional Fe3O4 nanoparticles was achieved via conjugation with a HER2 antibody. Several ligands and antibodies have been conjugated for active drug targeting and imaging.207 Biological macromolecules modified on Fe3O4 nanoparticles can be combined with specific cytokines in tumor cells to improve the absorption efficiency of Fe3O4 nanoparticles; such\n18 J. Biomed. Nanotechnol. 12, 1–27, 2016\nJ. Biomed. Nanotechnol. 12, 1–27, 2016 19\n20 J. Biomed. Nanotechnol. 12, 1–27, 2016\nDelivered by Publishing Technology to: Rice University IP: 208.98.249.39 On: Wed, 23 Dec 2015 17:22:25\nCopyright: American Scientific Publishers\nnanoparticles exhibit low immunogenicity and high stability. Magnetic Fe3O4 nanoparticles coated with lactoferrin or ceruloplasmin have been prepared and characterized by various physicochemical means in vitro. Lactoferrin- or ceruloplasmin-derivatized Fe3O4 nanoparticles target the surfaces of cells with little effect on the cytoskeleton and thus may serve as a non-toxic means of drug targeting.208\nAn engineered protein G system as a vehicle for the simultaneous intracellular delivery of functional nanoparticles and targeting antibodies has been reported. The engineered proteins were successfully combined with gold-coated magnetic nanoparticles for targeted cellular imaging and manipulation of mitochondria for organelle separation. The nanoparticle/antibody/engineered protein G hybrids could be used as a multifunctional platform for the targeting, imaging, and manipulation of specific intracellular biomolecules or organelles.209 Based on the above nanostructured inorganic material-based drug delivery systems, a summary of the type, modification/functionalization, characteristics, and applications of inorganic nanocarriers is provided in Table I."
    }, {
      "heading" : "SUMMARY AND OUTLOOK",
      "text" : "Nanostructures are novel entrants to the world of drug delivery systems. The past decade has witnessed the rapid development of novel nanostructures and hybrid nanostructures in the field of nanomedicine. In this review, we have discussed the importance of the size-, shape-, composition-, and surface-dependent physical and chemical properties of various nanostructures for drug delivery systems. We have also outlined the unique characteristics of different types of nanomaterials in drug delivery applications. In addition, we highlighted some recent exciting research on various nanostructures as sustained release systems and stimuli-responsive controlled-release systems. Among them, multifunctional nanomaterials with luminescence and/or magnetism, a mesoporous structure, and/or smart polymers can provide a new generation of drug carriers that enable site-, time- and dose-selected drug release, bioimaging, and simultaneous diagnosis and therapy.\nRecent developments in nanomaterials and nanotechnology are encouraging and indicate great potential for drug delivery applications, but several key challenges remain for further application of drug delivery systems in the biological and biomedical fields. First, although there are many reports on single nanostructures and multi-functionalized nanostructures with high surface areas and special physical/chemical properties that enable high drug loading and low release rates, large-scale synthesis remains challenging, which limits the practical applications of these materials. The development of improved synthetic routes and detailed structure-function studies are urgently needed. Second, the biological effects of nanostructured drug carriers are sometimes conflicting, which may be due to the different methods used to prepare and treat the nanoparticles.\nTherefore, further detailed investigations are needed to develop standardized methods for the evaluation of the biological impacts of nanostructures before they can be used in clinical trials. Third, nanotoxicology cannot be ignored because the biosafety of nanostructures is the foundation for their biomedical applications. However, most nanostructures have been studied in an in vitro environment. Further in vivo investigations of pharmacokinetics, pharmacodynamics, and metabolism in animal models must be conducted before these nanostructures can be used in humans. Such studies would also facilitate the design of highly effective drug delivery systems. Finally, although combining imaging, targeting and drug delivery functions into one drug delivery system will offer exciting opportunities for biomedical applications of nanostructures, special attention should be paid to the interactions between the drug and imaging probe, controlled drug delivery and release strategies, and accurate imaging of the drug and drug carriers.\nAcknowledgments: This research was supported by the National Natural Science Foundation of China (31470961, 21001038, 21271059, 21301046, 51302062), the Research Fund for the Doctoral Program of Higher Education of China (20111301110004, 20131301120004), the Hebei Province “Hundred Talents Program” (BR2-202), the China Postdoctoral Science Foundation (2013M530119), the Natural Science Foundation of Hebei Province (B2012201074), the Hebei Province “Three Three Three Talents Program” (A201401002) the Outstanding Youth Fund Project (Y2012007) of Hebei Education Department, the Training Program for Innovative Research Team and Leading Talent in Hebei Province University (LJRC024), SRF for ROCS, SEM, the Key Basic Research Special Foundation of Science Technology Ministry of Hebei Province (Grant No. 14961302D), and Hebei Provincial Natural Science Foundation of China-Shijiazhuang Pharmaceutical Group (CSPC) Foundation (B2012201044). Professor Gang Ma is also acknowledged for providing English editing."
    } ],
    "references" : [ {
      "title" : "Nano-sized drug delivery systems for lymphatic delivery",
      "author" : [ "H.Y. Cho", "Y.B. Lee" ],
      "venue" : "J. Nanosci. Nanotechnol",
      "citeRegEx" : "2",
      "shortCiteRegEx" : "2",
      "year" : 2014
    }, {
      "title" : "Self-activated luminescent and mesoporous strontium hydroxyapatite nanorods for drug",
      "author" : [ "C. Zhang", "C. Li", "S. Huang", "Z. Hou", "Z. Cheng", "P. Yang", "C. Peng", "J. Lin" ],
      "venue" : "delivery. Biomaterials 31,",
      "citeRegEx" : "3",
      "shortCiteRegEx" : "3",
      "year" : 2010
    }, {
      "title" : "A field in the making",
      "author" : [ "K. Kostarelos", "The emergence of nanomedicine" ],
      "venue" : "Nanomedicine 1, 1",
      "citeRegEx" : "5",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Not just a matter of size",
      "author" : [ "C.L. Bai", "M.H. Liu", "From chemistry to nanoscience" ],
      "venue" : "Angew. Chem. Int. Ed. Engl. 52, 2678",
      "citeRegEx" : "6",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications",
      "author" : [ "J.E. Lee", "N. Lee", "T. Kim", "J. Kim", "T. Hyeon" ],
      "venue" : "Acc. Chem. Res",
      "citeRegEx" : "7",
      "shortCiteRegEx" : "7",
      "year" : 2011
    }, {
      "title" : "The past and the future",
      "author" : [ "Y. Zhang", "H.F. Chan", "K.W. Leong", "Advanced materials", "processing for drug delivery" ],
      "venue" : "Adv. Drug Deliv. Rev. 65, 104",
      "citeRegEx" : "8",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Mesoporous silica nanoparticles in biomedical applications",
      "author" : [ "Z. Li", "J.C. Barnes", "A. Bosoy", "J.F. Stoddartbc", "J.I. Zink" ],
      "venue" : "Chem. Soc. Rev",
      "citeRegEx" : "9",
      "shortCiteRegEx" : "9",
      "year" : 2012
    }, {
      "title" : "Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems",
      "author" : [ "P. Yang", "Z. Quan", "L. Lu", "S. Huang", "J. Lin" ],
      "venue" : "Biomaterials 29,",
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2008
    }, {
      "title" : "Coordination polymer coated mesoporous silica nanoparticles for pH-responsive drug release",
      "author" : [ "L. Xing", "H. Zheng", "Y. Cao", "S. Che" ],
      "venue" : "Adv. Mater",
      "citeRegEx" : "11",
      "shortCiteRegEx" : "11",
      "year" : 2012
    }, {
      "title" : "Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment",
      "author" : [ "F. Yang", "C. Jin", "S. Subedi", "C.L. Lee", "Q. Wang", "Y. Jiang", "J. Li", "Y. Di", "D. Fu" ],
      "venue" : "Cancer Treat. Rev. 38,",
      "citeRegEx" : "12",
      "shortCiteRegEx" : "12",
      "year" : 2012
    }, {
      "title" : "Enhanced efficacy by folate modification",
      "author" : [ "J. Lu", "Z. Li", "J.I. Zink", "F. Tamanoi", "In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system" ],
      "venue" : "Nanomedicine 8, 212",
      "citeRegEx" : "13",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Synthesis, biocompatibility and drug delivery",
      "author" : [ "F.Q. Tang", "L.L. Li", "D. Chen", "Mesoporous silica nanoparticles" ],
      "venue" : "Adv. Mater. 24, 1504",
      "citeRegEx" : "14",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Functionalized mesoporous silica materials for controlled drug",
      "author" : [ "P. Yang", "S.L. Gai", "J. Lin" ],
      "venue" : "delivery. Chem. Soc. Rev",
      "citeRegEx" : "15",
      "shortCiteRegEx" : "15",
      "year" : 2012
    }, {
      "title" : "Drug delivery system",
      "author" : [ "M. Vallet-Regi", "A. Rámila", "R.P. del Real", "J. Pérez-Pariente", "A new property of MCM-41" ],
      "venue" : "Chem. Mater. 13, 308",
      "citeRegEx" : "16",
      "shortCiteRegEx" : null,
      "year" : 2001
    }, {
      "title" : "Bone-regenerative bioceramic implants with drug and protein controlled delivery capability",
      "author" : [ "F. Balas", "M. Colilla", "M. Manzano" ],
      "venue" : "Prog. Solid State Chem. 36,",
      "citeRegEx" : "17",
      "shortCiteRegEx" : "17",
      "year" : 2008
    }, {
      "title" : "Ordered mesoporous materials in the context of drug delivery systems and bone tissue",
      "author" : [ "M. Vallet-Regi" ],
      "venue" : "engineering. Chem. Eur. J",
      "citeRegEx" : "18",
      "shortCiteRegEx" : "18",
      "year" : 2006
    }, {
      "title" : "Facile and controllable synthesis of monodisperse CaF2 and CaF2:Ce  3+/Tb3+ hollow spheres as efficient luminescent materials and smart drug",
      "author" : [ "C.M. Zhang", "C.X. Li", "C. Peng", "R.T. Chai", "S.S. Huang", "D.M. Yang Z. Cheng", "J. Lin" ],
      "venue" : "carriers. Chem. Eur. J. 16,",
      "citeRegEx" : "20",
      "shortCiteRegEx" : "20",
      "year" : 2010
    }, {
      "title" : "Fabrication of uniform hollow mesoporous silica spheres and ellipsoids of tunable size through a facile hard-templating route",
      "author" : [ "W. Zhao", "M. Lang", "Y. Li", "L. Lia", "J.L. Shi" ],
      "venue" : "J. Mater. Chem",
      "citeRegEx" : "22",
      "shortCiteRegEx" : "22",
      "year" : 2009
    }, {
      "title" : "A facile route to hollow nanospheres of mesoporous silica with tunable size",
      "author" : [ "Z. Feng", "Y. Li", "D. Niu", "L. Li", "W. Zhao", "H. Chen", "J. Gao", "M. Ruan", "J. Shi" ],
      "venue" : "Chem. Comm",
      "citeRegEx" : "23",
      "shortCiteRegEx" : "23",
      "year" : 2008
    }, {
      "title" : "The role of the sinus wall in the passage of erythrocytes through the spleen",
      "author" : [ "L.T. Chen", "L. Weiss" ],
      "venue" : "Blood 41,",
      "citeRegEx" : "24",
      "shortCiteRegEx" : "24",
      "year" : 1973
    }, {
      "title" : "An ideal nanoreactor for the preparation of tunable gold cores",
      "author" : [ "L. Tan", "D. Chen", "H. Liu", "F.Q. Tang", "A silica nanorattle with a mesoporous shell" ],
      "venue" : "Adv. Mater. 22, 4885",
      "citeRegEx" : "25",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Uniform rattle-type hollow magnetic mesoporous spheres as drug delivery carriers and their sustained-release property",
      "author" : [ "W. Zhao", "H. Chen", "Y. Li", "L. Li", "M. Lang", "J.L. Shi" ],
      "venue" : "Adv. Funct. Mater",
      "citeRegEx" : "26",
      "shortCiteRegEx" : "26",
      "year" : 2008
    }, {
      "title" : "Hollow/rattle-type mesoporous nanostructures by a structural difference-based selective etching strategy",
      "author" : [ "Y. Chen", "H. Chen", "L. Guo", "Q. He", "F. Chen", "J. Zhou", "J. Feng", "L. Shi" ],
      "venue" : "ACS Nano 4,",
      "citeRegEx" : "27",
      "shortCiteRegEx" : "27",
      "year" : 2010
    }, {
      "title" : "Shell-by-shell synthesis of multi-shelled mesoporous silica nanospheres for optical imaging and drug",
      "author" : [ "C.C. Huang", "W. Huang", "C.S. Yeh" ],
      "venue" : "delivery. Biomaterials 32,",
      "citeRegEx" : "28",
      "shortCiteRegEx" : "28",
      "year" : 2011
    }, {
      "title" : "Mechanical capping of silica nanotubes for encapsulation of molecules",
      "author" : [ "J. Yu", "X. Bai", "J. Suh", "S.B. Lee", "S.J. Son" ],
      "venue" : "J. Am. Chem",
      "citeRegEx" : "30",
      "shortCiteRegEx" : "30",
      "year" : 2009
    }, {
      "title" : "An antiROS/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles",
      "author" : [ "Q. He", "J. Zhang", "F. Chen", "L. Guo", "Z. Zhu", "J.L. Shi" ],
      "venue" : "Biomaterials 31,",
      "citeRegEx" : "34",
      "shortCiteRegEx" : "34",
      "year" : 2010
    }, {
      "title" : "Core–Shell structured up-conversion luminescent and mesoporous NaYF4:Yb /Er@nSiO2@mSiO2 nanospheres as carriers for drug",
      "author" : [ "X. Kang", "Z. Cheng", "C. Li", "D. Yang", "M. Shang", "P. Ma", "G. Li", "N. Liu", "J. Lin" ],
      "venue" : "delivery. J. Phys. Chem. C 115,",
      "citeRegEx" : "36",
      "shortCiteRegEx" : "36",
      "year" : 2011
    }, {
      "title" : "Facile synthesis of an up-conversion luminescent and mesoporous Gd2O3:Er  @nSiO2@mSiO2 nanocomposite as a drug carrier",
      "author" : [ "Z. Xu", "C. Li", "P. Ma", "Z. Hou", "D. Yang", "X. Kang", "J. Lin" ],
      "venue" : "Nanoscale 3,",
      "citeRegEx" : "37",
      "shortCiteRegEx" : "37",
      "year" : 2011
    }, {
      "title" : "Electrospinning preparation and drug-delivery properties of an up-conversion luminescent porous  NaYF4:Yb 3+,Er3+@Silica fiber nanocomposite",
      "author" : [ "Z. Hou", "C. Li", "P. Ma", "G. Li", "Z. Cheng", "C. Peng", "Y. Dai", "J. Lin" ],
      "venue" : "Adv. Funct. Mater",
      "citeRegEx" : "38",
      "shortCiteRegEx" : "38",
      "year" : 2011
    }, {
      "title" : "Controlled synthesis and water dispersibility of hexagonal phase NaGdF4:Ho  3+/Yb3+ nanoparticles",
      "author" : [ "R. Naccache", "F. Vetrone", "V. Mahalingam", "L.A. Cuccia", "J.A. Capobianco" ],
      "venue" : "Chem. Mater. 21,",
      "citeRegEx" : "39",
      "shortCiteRegEx" : "39",
      "year" : 2009
    }, {
      "title" : "Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals",
      "author" : [ "D.K. Chatterjeea", "A.J. Rufaihaha", "Y. Zhang" ],
      "venue" : "Biomaterials 29,",
      "citeRegEx" : "40",
      "shortCiteRegEx" : "40",
      "year" : 2008
    }, {
      "title" : "A magnetic, luminescent and mesoporous core–shell structured composite material as drug carrier",
      "author" : [ "P. Yang", "Z. Quan", "Z. Hou", "C. Li", "X. Kang", "Z. Cheng", "J. Lin" ],
      "venue" : "Biomaterials 30,",
      "citeRegEx" : "41",
      "shortCiteRegEx" : "41",
      "year" : 2009
    }, {
      "title" : "Up-conversion cell imaging and pH-induced thermally controlled drug release from NaYF4/Yb  3+/Er3+@hydrogel core–shell hybrid microspheres",
      "author" : [ "Y. Dai", "P. Ma", "Z. Cheng", "X. Kang", "X. Zhang", "Z. Hou", "X. Li", "D. Yang", "X. Zhai", "J. Lin" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "42",
      "shortCiteRegEx" : "42",
      "year" : 2012
    }, {
      "title" : "pH-operated nanopistons on the surfaces of mesoporous silica nanoparticles",
      "author" : [ "Y.L. Zhao", "Z. Li", "S. Kabehie", "Y.Y. Botros", "J.F. Stoddart", "J.I. Zink" ],
      "venue" : "J. Am. Chem",
      "citeRegEx" : "43",
      "shortCiteRegEx" : "43",
      "year" : 2010
    }, {
      "title" : "Controlled-access hollow mechanized silica nanocontainers",
      "author" : [ "L. Du", "S. Liao", "H.A. Khatib", "J.F. Stoddart", "J.I. Zink" ],
      "venue" : "J. Am. Chem. Soc",
      "citeRegEx" : "44",
      "shortCiteRegEx" : "44",
      "year" : 2009
    }, {
      "title" : "Multifunctional magnetic-fluorescent eccentric-(concentricFe3O4@SiO2@polyacrylic acid core–shell nanocomposites for cell imaging and pH-responsive drug",
      "author" : [ "L. Li", "C. Liu", "L. Zhang", "T. Wang", "H. Yu", "C. Wang", "Z. Su" ],
      "venue" : "delivery. Nanoscale",
      "citeRegEx" : "45",
      "shortCiteRegEx" : "45",
      "year" : 2013
    }, {
      "title" : "Stimuli-responsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core– shell structure",
      "author" : [ "Y.F. Zhu", "J.L. Shi", "W.H. Shen", "X.P. Dong", "J.W. Feng", "M.L. Ruan", "Y. Li" ],
      "venue" : "Angew. Chem. Int. Ed. Engl",
      "citeRegEx" : "46",
      "shortCiteRegEx" : "46",
      "year" : 2005
    }, {
      "title" : "Synthesis and characterization",
      "author" : [ "B.S. Tian", "C. Yang", "Temperature-responsive nanocomposites based on mesoporous SBA-15 silica", "PNIPAAm" ],
      "venue" : "J. Phys. Chem. C 113, 4925",
      "citeRegEx" : "47",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Temperature responsive solution partition of organic–inorganic hybrid poly(N isopropylacrylamide)-coated mesoporous silica nanospheres",
      "author" : [ "P.W. Chung", "R. Kumar", "M. Pruski", "V.S.Y. Lin" ],
      "venue" : "Adv. Funct. Mater",
      "citeRegEx" : "48",
      "shortCiteRegEx" : "48",
      "year" : 2008
    }, {
      "title" : "Design and synthesis of multifunctional drug carriers based on luminescent rattle-type mesoporous silica microspheres with a thermosensitive hydrogel as a controlled switch",
      "author" : [ "X.J. Kang", "Z.Y. Cheng", "D.M. Yang", "P. Ma", "M.M. Shang", "C. Peng", "J. Lin" ],
      "venue" : "Adv. Funct. Mater. 22,",
      "citeRegEx" : "49",
      "shortCiteRegEx" : "49",
      "year" : 2012
    }, {
      "title" : "A programmable DNA-based molecular valve for colloidal mesoporous silica",
      "author" : [ "A. Schlossbauer", "S. Warncke", "P.M.E. Gramlich", "J. Kecht", "A. Manetto", "T. Carell", "T. Bein" ],
      "venue" : "Angew. Chem. Int. Ed. Engl",
      "citeRegEx" : "50",
      "shortCiteRegEx" : "50",
      "year" : 2010
    }, {
      "title" : "Vallet-Regí, Smart drug delivery through DNA/magnetic nanoparticle gates",
      "author" : [ "E. Ruiz-Hernández", "A. Baeza" ],
      "venue" : "ACS nano 5,",
      "citeRegEx" : "51",
      "shortCiteRegEx" : "51",
      "year" : 2011
    }, {
      "title" : "Multifunctional hybrid silica nanoparticles for controlled doxorubicin loading and release with thermal and pH dually response",
      "author" : [ "X. Hu", "X. Hao", "Y. Wu", "J. Zhang", "X. Zhang", "P.C. Wang", "G. Zou", "X. Liang" ],
      "venue" : "J. Mater. Chem. B",
      "citeRegEx" : "52",
      "shortCiteRegEx" : "52",
      "year" : 2013
    }, {
      "title" : "Synthesis and application as stimuli-responsive nanocontainers in self-healing coatings",
      "author" : [ "G.L. Li", "Z. Zheng", "H. Möhwald", "D.G. Shchukin", "Silica/polymer double-walled hybrid nanotubes" ],
      "venue" : "ACS Nano 7, 2470",
      "citeRegEx" : "53",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Light-activated nanoimpeller-controlled drug release in cancer cells",
      "author" : [ "J. Lu", "E. Choi", "F. Tamanoi", "J.I. Zink" ],
      "venue" : "Small 4,",
      "citeRegEx" : "54",
      "shortCiteRegEx" : "54",
      "year" : 2008
    }, {
      "title" : "Light- and pHresponsive release of doxorubicin from a mesoporous silica-based nanocarrier",
      "author" : [ "N.Ž. Knežević", "B.G. Trewyn", "V.S.Y. Lin" ],
      "venue" : "Chem. Eur. J. 17,",
      "citeRegEx" : "55",
      "shortCiteRegEx" : "55",
      "year" : 2011
    }, {
      "title" : "Paclitaxel loaded fibrinogen coated CdTe/ZnTe core shell nanoparticles for targeted imaging and drug delivery to breast cancer cells",
      "author" : [ "N.S. Rejinold", "T. Baby", "S.V. Nair", "R. Jayakumar" ],
      "venue" : "J. Biomed. Nanotechnol",
      "citeRegEx" : "57",
      "shortCiteRegEx" : "57",
      "year" : 2013
    }, {
      "title" : "Their optical and photovoltaic properties",
      "author" : [ "J. Bang", "J. Park", "J.H. Lee", "N. Won", "J. Nam", "J. Lim", "B.Y. Chang", "H.J. Lee", "B. Chon", "J. Shin", "J.B. Park", "J.H. Choi", "K. Cho", "S.M. Park", "T. Joo", "S. Kim", "ZnTe/ZnSe (Core/Shell) type-II quantum dots" ],
      "venue" : "Chem. Mater. 22, 233",
      "citeRegEx" : "58",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Preparation of zein conjugated quantum dots and their in vivo transdermal delivery capacity through nude mouse skin",
      "author" : [ "L. Wang", "G. Qin", "S. Geng", "Y. Dai", "J.Y. Wang" ],
      "venue" : "J. Biomed. Nanotechnol",
      "citeRegEx" : "60",
      "shortCiteRegEx" : "60",
      "year" : 2013
    }, {
      "title" : "Designing multifunctional quantum dots for bioimaging, detection, and drug",
      "author" : [ "P. Zrazhevskiy", "M. Sena", "X. Gao" ],
      "venue" : "delivery. Chem. Soc. Rev",
      "citeRegEx" : "61",
      "shortCiteRegEx" : "61",
      "year" : 2010
    }, {
      "title" : "Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery",
      "author" : [ "M. Liong", "J. Lu", "M. Kovochich", "T. Xia", "S.G. Ruehm", "A.E. Nel", "F. Tamanoi", "J.I. Zink" ],
      "venue" : "ACS Nano 2,",
      "citeRegEx" : "62",
      "shortCiteRegEx" : "62",
      "year" : 2008
    }, {
      "title" : "Quantum dots, lighting up the research and development of nanomedicine",
      "author" : [ "Y. Wang", "L. Chen" ],
      "venue" : "Nanomedicine 7,",
      "citeRegEx" : "63",
      "shortCiteRegEx" : "63",
      "year" : 2011
    }, {
      "title" : "Application of quantum dots in biological imaging",
      "author" : [ "S. Jin", "Y. Hu", "Z. Gu", "L. Liu", "H.C. Wu" ],
      "venue" : "J. Nanomater. 2011,",
      "citeRegEx" : "64",
      "shortCiteRegEx" : "64",
      "year" : 2011
    }, {
      "title" : "In vivo cancer targeting and imaging with semiconductor quantum dots",
      "author" : [ "X. Gao", "Y. Cui", "R.M. Levenson", "L.W. Chung", "S. Nie" ],
      "venue" : "Nat. Biotechnol",
      "citeRegEx" : "65",
      "shortCiteRegEx" : "65",
      "year" : 2004
    }, {
      "title" : "In vivo molecular and cellular imaging with quantum dots",
      "author" : [ "X. Gao", "L. Yang", "J.A. Petros", "F.F. Marshall", "J.W. Simons", "S. Nie" ],
      "venue" : "Curr. Opin. Biotech. 16,",
      "citeRegEx" : "67",
      "shortCiteRegEx" : "67",
      "year" : 2005
    }, {
      "title" : "Libchaber, In vivo imaging of quantum dots encapsulated in phospholipid micelles",
      "author" : [ "B. Dubertret", "P. Skourides", "D.J. Norris", "V. Noireaux", "A.H. Brivanlou" ],
      "venue" : "Science 298,",
      "citeRegEx" : "68",
      "shortCiteRegEx" : "68",
      "year" : 2002
    }, {
      "title" : "Longterm multiple color imaging of live cells using quantum dot bioconjugates",
      "author" : [ "J.K. Jaiswal", "H. Mattoussi", "J.M. Mauro", "S.M. Simon" ],
      "venue" : "Nat. Biotechnol. 21,",
      "citeRegEx" : "69",
      "shortCiteRegEx" : "69",
      "year" : 2002
    }, {
      "title" : "Quantum dots for in vivo small-animal imaging",
      "author" : [ "L.A. Bentolila", "Y. Ebenstein", "S. Weiss" ],
      "venue" : "J. Nucl. Med",
      "citeRegEx" : "70",
      "shortCiteRegEx" : "70",
      "year" : 2009
    }, {
      "title" : "In vivo quantum-dot toxicity assessment",
      "author" : [ "T.S. Hauck", "R.E. Anderson", "H.C. Fischer", "S. Newbigging", "W.C. Chan" ],
      "venue" : "Small 6,",
      "citeRegEx" : "71",
      "shortCiteRegEx" : "71",
      "year" : 2010
    }, {
      "title" : "Long-term exposure to CdTe quantum dots causes functional impairments in live cells",
      "author" : [ "S.J. Cho", "D. Maysinger", "M. Jain", "B. Röder", "S. Hackbarth", "F.M. Winnik" ],
      "venue" : "Langmuir 23,",
      "citeRegEx" : "72",
      "shortCiteRegEx" : "72",
      "year" : 2007
    }, {
      "title" : "Water-soluble quantum dots for biomedical applications",
      "author" : [ "W.W. Yu", "E. Chang", "R. Drezek", "V.L. Colvin" ],
      "venue" : "Biochem. Biophys. Res. Commun. 348,",
      "citeRegEx" : "73",
      "shortCiteRegEx" : "73",
      "year" : 2006
    }, {
      "title" : "Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification",
      "author" : [ "A. Hoshino", "K. Fujioka", "T. Oku", "M. Suga", "Y.F. Sasaki", "T. Ohta", "M. Yasuhara", "K. Suzuki", "K. Yamamoto" ],
      "venue" : "Nano Lett",
      "citeRegEx" : "74",
      "shortCiteRegEx" : "74",
      "year" : 2004
    }, {
      "title" : "Preparation of quantum dot/drug nanoparticle formulations for traceable targeted delivery and therapy",
      "author" : [ "K.T. Yong", "Y. Wang", "I. Roy", "H. Rui", "M.T. Swihart", "W.-C. Law", "S.K. Kwak", "L. Ye", "J. Liu", "S.D. Mahajan" ],
      "venue" : "Theranostics 2,",
      "citeRegEx" : "75",
      "shortCiteRegEx" : "75",
      "year" : 2012
    }, {
      "title" : "Quantum dot as a drug tracer in vivo",
      "author" : [ "N. Manabe", "A. Hoshino", "Y. Liang", "T. Goto", "N. Kato", "K. Yamamoto" ],
      "venue" : "IEEE Trans. Nanobioscience",
      "citeRegEx" : "76",
      "shortCiteRegEx" : "76",
      "year" : 2006
    }, {
      "title" : "Volkovc, Optimisation of the synthesis and modification of CdTe quantum dots for enhanced live cell imaging",
      "author" : [ "S.J. Byrne", "S.A. Corr", "T.Y. Rakovich", "Y.K. Gun’ko", "Y.P. Rakovich", "J.F. Donegan", "S. Mitchellc" ],
      "venue" : "J. Mater. Chem",
      "citeRegEx" : "77",
      "shortCiteRegEx" : "77",
      "year" : 2006
    }, {
      "title" : "A multifunctional nanocarrier system for cancer diagnosis and treatment",
      "author" : [ "H.S. Cho", "Z. Dong", "G.M. Pauletti", "J. Zhang", "H. Xu", "H. Gu", "L. Wang", "R.C. Ewing", "C. Huth", "F. Wang", "D. Shi", "Fluorescent", "superparamagnetic nanospheres for drug storage", "targeting", "imaging" ],
      "venue" : "ACS nano 4, 5398",
      "citeRegEx" : "80",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Delivery of quantum dot-siRNA nanoplexes in SK-N-SH cells for BACE1 gene silencing and intracellular imaging",
      "author" : [ "S. Li", "Z. Liu", "F. Ji", "Z. Xiao", "M. Wang", "Y. Peng", "Y. Zhang", "L. Liu", "Z. Liang", "F. Li" ],
      "venue" : "Mol. Ther. Nucleic Acids 1,",
      "citeRegEx" : "81",
      "shortCiteRegEx" : "81",
      "year" : 2012
    }, {
      "title" : "Generation of a library of non-toxic quantum dots for cellular imaging and siRNA delivery",
      "author" : [ "P. Subramaniam", "S.J. Lee", "S. Shah", "S. Patel", "V. Starovoytov", "K.B. Lee" ],
      "venue" : "Adv. Mater",
      "citeRegEx" : "82",
      "shortCiteRegEx" : "82",
      "year" : 2012
    }, {
      "title" : "Quantum dots to monitor RNAi delivery and improve gene silencing",
      "author" : [ "A.A. Chen", "A.M. Derfus", "S.R. Khetani", "S.N. Bhatia" ],
      "venue" : "Nucleic Acids Res. 33,",
      "citeRegEx" : "84",
      "shortCiteRegEx" : "84",
      "year" : 2005
    }, {
      "title" : "An oligonucleotide microarray for microRNA expression analysis based on labeling RNA with quantum dot and nanogold probe",
      "author" : [ "R.Q. Liang", "W. Li", "Y. Li", "C. Tan", "J.X. Li", "Y.X. Jin", "K.C. Ruan" ],
      "venue" : "Nucleic Acids Res. 33,",
      "citeRegEx" : "85",
      "shortCiteRegEx" : "85",
      "year" : 2005
    }, {
      "title" : "Intracellular delivery of quantum dots tagged antisense oligodeoxynucleotides by functionalized multiwalled carbon nanotubes",
      "author" : [ "N. Jia", "Q. Lian", "H. Shen", "C. Wang", "X. Li", "Z. Yang" ],
      "venue" : "Nano Lett",
      "citeRegEx" : "86",
      "shortCiteRegEx" : "86",
      "year" : 2007
    }, {
      "title" : "MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier",
      "author" : [ "A. Bonoiu", "S.D. Mahajan", "L. Ye", "R. Kumar", "H. Ding", "K.T. Yong", "I. Roy", "R. Aalinkeel", "B. Nair", "J.L. Reynolds", "D.E. Sykes", "M.A. Imperiale", "E.J. Bergey", "S.A. Schwartz", "P.N. Prasad" ],
      "venue" : "Brain Res. 1282,",
      "citeRegEx" : "87",
      "shortCiteRegEx" : "87",
      "year" : 2009
    }, {
      "title" : "Quantum dot-amphipol nanocomplex for intracellular delivery and real-time imaging of siRNA",
      "author" : [ "L. Qi", "X. Gao" ],
      "venue" : "ACS Nano 2,",
      "citeRegEx" : "88",
      "shortCiteRegEx" : "88",
      "year" : 2008
    }, {
      "title" : "Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging",
      "author" : [ "M.V. Yezhelyev", "L. Qi", "R.M. O’Regan", "S. Nie", "X. Gao" ],
      "venue" : "J. Am. Chem",
      "citeRegEx" : "89",
      "shortCiteRegEx" : "89",
      "year" : 2008
    }, {
      "title" : "Targeted quantum dot conjugates for siRNA delivery",
      "author" : [ "A.M. Derfus", "A.A. Chen", "D.-H. Min", "E. Ruoslahti", "S.N. Bhatia" ],
      "venue" : "Bioconjug. Chem",
      "citeRegEx" : "90",
      "shortCiteRegEx" : "90",
      "year" : 2007
    }, {
      "title" : "Tumor targeting of functionalized quantum dot-liposome hybrids by intravenous administration",
      "author" : [ "W.T. Al-Jamal", "K.T. Al-Jamal", "B. Tian", "A. Cakebread", "J.M. Halket", "K. Kostarelos" ],
      "venue" : "Mol. Pharm. 6,",
      "citeRegEx" : "93",
      "shortCiteRegEx" : "93",
      "year" : 2009
    }, {
      "title" : "Ultrafine biocompatible chitosan nanoparticles encapsulating multi-coloured quantum dots for bioapplications",
      "author" : [ "W.B. Tan", "N. Huang", "Y. Zhang" ],
      "venue" : "J. Colloid Interface Sci. 310,",
      "citeRegEx" : "94",
      "shortCiteRegEx" : "94",
      "year" : 2007
    }, {
      "title" : "In vivo imaging and drug storage by quantum-dot-conjugated carbon nanotubes",
      "author" : [ "Y. Guo", "D. Shi", "H. Cho", "Z. Dong", "A. Kulkarni", "G.M. Pauletti", "W. Wang", "J. Lian", "W. Liu", "L. Ren" ],
      "venue" : "Adv. Funct. Mater",
      "citeRegEx" : "95",
      "shortCiteRegEx" : "95",
      "year" : 2008
    }, {
      "title" : "Multifunctional quantum-dot-based magnetic chitosan nanobeads",
      "author" : [ "W.B. Tan", "Y. Zhang" ],
      "venue" : "Adv. Mater",
      "citeRegEx" : "97",
      "shortCiteRegEx" : "97",
      "year" : 2005
    }, {
      "title" : "Buckminsterfullerene",
      "author" : [ "H.W. Kroto", "J.R. Heath", "S.C. O’Brien", "R.F. Curl", "R.E. Smalley", "C60" ],
      "venue" : "Nature 318, 162",
      "citeRegEx" : "98",
      "shortCiteRegEx" : null,
      "year" : 1985
    }, {
      "title" : "Nanotubes from carbon",
      "author" : [ "P.M. Ajayan" ],
      "venue" : "Chem. Rev. 99,",
      "citeRegEx" : "99",
      "shortCiteRegEx" : "99",
      "year" : 1999
    }, {
      "title" : "Synthetic methodologies for carbon nanomaterials",
      "author" : [ "Z. Liu", "X. Zhou", "Y. Qian" ],
      "venue" : "Adv. Mater",
      "citeRegEx" : "100",
      "shortCiteRegEx" : "100",
      "year" : 1963
    }, {
      "title" : "Should you use nanotubes or graphene",
      "author" : [ "W. Yang", "K.R. Ratinac", "S.P. Ringer", "P. Thordarson", "J.J. Gooding", "F. Braet", "Carbon nanomaterials in biosensors" ],
      "venue" : "Angew. Chemie Int. Ed. Engl. 49, 2114",
      "citeRegEx" : "101",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Enzymes immobilized on carbon nanotubes",
      "author" : [ "W. Feng", "P. Ji" ],
      "venue" : "Biotechnol. Adv. 29,",
      "citeRegEx" : "102",
      "shortCiteRegEx" : "102",
      "year" : 2011
    }, {
      "title" : "Emergent nanolights",
      "author" : [ "S.N. Baker", "G.A. Baker", "Luminescent carbon nanodots" ],
      "venue" : "Angew. Chemie Int. Ed. Engl. 49, 6726",
      "citeRegEx" : "103",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Synthesis, properties, and biological applications",
      "author" : [ "J. Fan", "P.K. Chu", "Group IV nanoparticles" ],
      "venue" : "Small 6, 2080",
      "citeRegEx" : "104",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Covalent linkage of nanodiamondpaclitaxel for drug delivery and cancer therapy",
      "author" : [ "K.K. Liu", "W.W. Zheng", "C.C. Wang", "Y.C. Chiu", "C.L. Cheng", "Y.S. Lo", "C. Chen", "J.I. Chao" ],
      "venue" : "Nanotechnology 21,",
      "citeRegEx" : "106",
      "shortCiteRegEx" : "106",
      "year" : 2010
    }, {
      "title" : "Medical application of functionalized magnetic nanoparticles",
      "author" : [ "A. Ito", "M. Shinkai", "H. Honda", "T. Kobayashi" ],
      "venue" : "J. Biosci. Bioeng. 100,",
      "citeRegEx" : "107",
      "shortCiteRegEx" : "107",
      "year" : 2005
    }, {
      "title" : "Functional magnetic particles for medical application",
      "author" : [ "M. Shinkai" ],
      "venue" : "J. Biosci. Bioeng. 94,",
      "citeRegEx" : "108",
      "shortCiteRegEx" : "108",
      "year" : 2002
    }, {
      "title" : "The role of the sinus wall in the passage of erythrocytes through the spleen",
      "author" : [ "L.T. Chen", "L. Weiss" ],
      "venue" : "Blood 41,",
      "citeRegEx" : "109",
      "shortCiteRegEx" : "109",
      "year" : 1973
    }, {
      "title" : "One-step synthesis of fluorescent carbon nanoparticles by laser irradiation",
      "author" : [ "S.L. Hu", "K.Y. Niu", "J. Sun", "J. Yang", "N.Q. Zhao", "X.W. Du" ],
      "venue" : "J. Mater. Chem. 19,",
      "citeRegEx" : "110",
      "shortCiteRegEx" : "110",
      "year" : 2009
    }, {
      "title" : "Hollow luminescent carbon dots for drug",
      "author" : [ "Q. Wang", "X. Huang", "Y. Long", "X. Wang", "H. Zhang", "R. Zhu", "L. Liang", "P. Teng", "H. Zheng" ],
      "venue" : "delivery. Carbon 59,",
      "citeRegEx" : "111",
      "shortCiteRegEx" : "111",
      "year" : 2013
    }, {
      "title" : "Metallofullerene nanoparticles promote osteogenic differentiation of bone marrow stromal cells through BMP signaling pathway",
      "author" : [ "K. Yang", "W. Cao", "X. Hao", "X. Xue", "J. Zhao", "J. Liu", "Y. Zhao", "J. Meng", "B. Sun", "J. Zhang", "X. Liang" ],
      "venue" : "Nanoscale 5,",
      "citeRegEx" : "113",
      "shortCiteRegEx" : "113",
      "year" : 2013
    }, {
      "title" : "Shape effect of carbon nanovectors on angiogenesis",
      "author" : [ "P. Chaudhuri", "R. Harfouche", "S. Soni", "D.M. Hentschel", "S. Sengupta" ],
      "venue" : "ACS Nano 4,",
      "citeRegEx" : "114",
      "shortCiteRegEx" : "114",
      "year" : 2010
    }, {
      "title" : "Synthesis, characterization, and study of biological activity in tissue culture",
      "author" : [ "T.Y. Zakharian", "A. Seryshev", "B. Sitharaman", "B.E. Gilbert", "V. Knight", "L.J. Wilson", "A fullerene-paclitaxel chemotherapeutic" ],
      "venue" : "J. Am. Chem. Soc. 127, 12508",
      "citeRegEx" : "115",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "Aqueous compatible fullerene-doxorubicin conjugates",
      "author" : [ "F. Lu", "S.A. Haque", "S.-T. Yang", "P.G. Luo", "L. Gu", "A. Kitaygorodskiy", "H. Li", "S. Lacher", "Y.P. Sun" ],
      "venue" : "J. Phys. Chem. C 113,",
      "citeRegEx" : "116",
      "shortCiteRegEx" : "116",
      "year" : 2009
    }, {
      "title" : "Liquid filled nanoparticles as a drug delivery tool for protein therapeutics",
      "author" : [ "N. Venkatesan", "J. Yoshimitsu", "Y. Ito", "N. Shibata", "K. Takada" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "117",
      "shortCiteRegEx" : "117",
      "year" : 2005
    }, {
      "title" : "Functionalized fullerenes in water. The first 10 years of their chemistry, biology, and nanoscience",
      "author" : [ "E. Nakamura", "H. Isobe" ],
      "venue" : "Acc. Chem. Res",
      "citeRegEx" : "118",
      "shortCiteRegEx" : "118",
      "year" : 2003
    }, {
      "title" : "In vivo gene delivery by cationic tetraamino fullerene",
      "author" : [ "R. Maeda-Mamiya", "E. Noiri", "H. Isobe", "W. Nakanishi", "K. Okamoto", "K. Doi", "T. Sugaya", "T. Izumi", "T. Homma", "E. Nakamura" ],
      "venue" : "Proc. Natl. Acad. Sci. U.S.A",
      "citeRegEx" : "119",
      "shortCiteRegEx" : "119",
      "year" : 2010
    }, {
      "title" : "A roadmap for graphene",
      "author" : [ "K.S. Novoselov", "V.I. Fal", "L. Colombo", "P.R. Gellert", "M.G. Schwab", "K. Kim" ],
      "venue" : "Nature 490,",
      "citeRegEx" : "120",
      "shortCiteRegEx" : "120",
      "year" : 2012
    }, {
      "title" : "Nano-graphene oxide for cellular imaging and drug delivery",
      "author" : [ "X. Sun", "Z. Liu", "K. Welsher", "J.T. Robinson", "A. Goodwin", "S. Zaric", "H. Dai" ],
      "venue" : "Nano Res",
      "citeRegEx" : "121",
      "shortCiteRegEx" : "121",
      "year" : 2008
    }, {
      "title" : "Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery",
      "author" : [ "Z. Liu", "X. Sun", "N. Nakayama-Ratchford", "H. Dai" ],
      "venue" : "ACS Nano 1,",
      "citeRegEx" : "122",
      "shortCiteRegEx" : "122",
      "year" : 2007
    }, {
      "title" : "Inhibition of proliferation and differentiation of mesenchymal stem cells by carboxylated carbon nanotubes",
      "author" : [ "D. Liu", "C. Yi", "D. Zhang", "J. Zhang", "M. Yang" ],
      "venue" : "ACS Nano 4,",
      "citeRegEx" : "123",
      "shortCiteRegEx" : "123",
      "year" : 2010
    }, {
      "title" : "Single-walled carbon",
      "author" : [ "M.D. Santi", "A. Antonelli", "M. Menotta", "C. Sfara", "S. Serafini", "S. Lucarini", "G. Brandi", "M. Magnani" ],
      "venue" : "J. Biomed. Nanotechnol. 12,",
      "citeRegEx" : "124",
      "shortCiteRegEx" : "124",
      "year" : 2016
    }, {
      "title" : "In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice",
      "author" : [ "Z. Liu", "W. Cai", "L. He", "N. Nakayama", "K. Chen", "X. Sun", "X. Chen", "H. Dai" ],
      "venue" : "Nat. Nanotechnol. 2,",
      "citeRegEx" : "126",
      "shortCiteRegEx" : "126",
      "year" : 2006
    }, {
      "title" : "Selective probing and imaging of cells with single walled carbon nanotubes as nearinfrared fluorescent molecules",
      "author" : [ "K. Welsher", "Z. Liu", "D. Daranciang", "H. Dai" ],
      "venue" : "Nano Lett. 8,",
      "citeRegEx" : "127",
      "shortCiteRegEx" : "127",
      "year" : 2008
    }, {
      "title" : "Multiplexed multicolor Raman imaging of live cells with isotopically modified single walled carbon nanotubes",
      "author" : [ "Z. Liu", "X. Li", "S.M. Tabakman", "K. Jiang", "S. Fan", "H. Dai" ],
      "venue" : "J. Am. Chem",
      "citeRegEx" : "128",
      "shortCiteRegEx" : "128",
      "year" : 2008
    }, {
      "title" : "Toward the construction of nanotube-based gene delivery vectors",
      "author" : [ "R. Singh", "D. Pantarotto", "D. McCarthy", "O. Chaloin", "J. Hoebeke", "C.D. Partidos", "J.P. Briand", "M. Prato", "A. Bianco", "K. Kostarelos", "Binding", "condensation of plasmid DNA onto functionalized carbon nanotubes" ],
      "venue" : "J. Am. Chem. Soc. 127, 4388",
      "citeRegEx" : "129",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "Applications of nanodiamonds in drug delivery and catalysis",
      "author" : [ "B. Moosa", "K. Fhayli", "S. Li", "K. Julfakyan", "A. Ezzeddine", "N.M. Khashab" ],
      "venue" : "J. Nanosci. Nanotechnol. 14,",
      "citeRegEx" : "132",
      "shortCiteRegEx" : "132",
      "year" : 2014
    }, {
      "title" : "Polymer-functionalized nanodiamond platforms as vehicles for gene delivery",
      "author" : [ "X.Q. Zhang", "M. Chen", "R. Lam", "X. Xu", "E. Osawa", "D. Ho" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "133",
      "shortCiteRegEx" : "133",
      "year" : 2009
    }, {
      "title" : "TATconjugated nanodiamond for the enhanced delivery of doxorubicin",
      "author" : [ "X. Li", "J. Shao", "Y. Qin", "C. Shao", "T. Zheng", "L. Ye" ],
      "venue" : "J. Mater. Chem",
      "citeRegEx" : "134",
      "shortCiteRegEx" : "134",
      "year" : 2011
    }, {
      "title" : "Dodging drug-resistant cancer with diamonds",
      "author" : [ "T.J. Merkel", "J.M. DeSimone" ],
      "venue" : "Sci. Transl. Med. 3,",
      "citeRegEx" : "135",
      "shortCiteRegEx" : "135",
      "year" : 2011
    }, {
      "title" : "Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment",
      "author" : [ "E.K. Chow", "X.-Q. Zhang", "M. Chen", "R. Lam", "E. Robinson", "H. Huang", "D. Schaffer", "E. Osawa", "A. Goga", "D. Ho" ],
      "venue" : "Sci. Transl. Med. 3,",
      "citeRegEx" : "136",
      "shortCiteRegEx" : "136",
      "year" : 2011
    }, {
      "title" : "Hollow/rattle-type mesoporous nanostructures by a structural difference-based selective etching strategy",
      "author" : [ "Y. Chen", "H. Chen", "L. Guo", "Q. He", "F. Chen", "J. Zhou", "J. Feng", "J. Shi" ],
      "venue" : "ACS Nano 4,",
      "citeRegEx" : "137",
      "shortCiteRegEx" : "137",
      "year" : 2009
    }, {
      "title" : "Multimodal nanodiamond drug delivery carriers for selective targeting, imaging, and enhanced chemotherapeutic efficacy",
      "author" : [ "X. Zhang", "R. Lam", "X. Xu", "E.K. Chow", "H. Kim", "D. Ho" ],
      "venue" : "Adv. Mater",
      "citeRegEx" : "138",
      "shortCiteRegEx" : "138",
      "year" : 2011
    }, {
      "title" : "Nanodiamonds as carriers for address delivery of biologically active substances",
      "author" : [ "K.V. Purtov", "A.I. Petunin", "A.E. Burov", "A.P. Puzyr", "V.S. Bondar" ],
      "venue" : "Nanoscale Res. Lett. 5,",
      "citeRegEx" : "139",
      "shortCiteRegEx" : "139",
      "year" : 2010
    }, {
      "title" : "Protein-mediated assembly of nanodiamond hydrogels into a biocompatible and biofunctional multilayer nanofilm",
      "author" : [ "H. Huang", "E. Pierstorff", "E. Osawa", "D. Ho" ],
      "venue" : "ACS Nano 2,",
      "citeRegEx" : "140",
      "shortCiteRegEx" : "140",
      "year" : 2008
    }, {
      "title" : "Nanodiamond-embedded microfilm devices for localized chemotherapeutic elution",
      "author" : [ "R. Lam", "M. Chen", "E. Pierstorff", "H. Huang", "E. Osawa", "D. Ho" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "141",
      "shortCiteRegEx" : "141",
      "year" : 2008
    }, {
      "title" : "Label-free detection of glycoproteins by the lectin biosensor down to attomolar level using gold nanoparticles",
      "author" : [ "T. Bertok", "A. Sediva", "J. Katrlik", "P. Gemeiner", "M. Mikula", "M. Nosko", "J. Tkac" ],
      "venue" : "Talanta 108,",
      "citeRegEx" : "142",
      "shortCiteRegEx" : "142",
      "year" : 2013
    }, {
      "title" : "Margartitondo, Very small photoluminescent gold nanoparticles for multimodality biomedical imaging",
      "author" : [ "S.F. Lai", "C.C. Chien", "W.C. Chen", "H.H. Chen", "Y.Y. Chen", "C.L. Wang", "Y. Hwu", "C.S. Yang", "C.Y. Chen", "K.S. Liang", "C. Petibois", "H.R. Tan", "E.S. Tok" ],
      "venue" : "Biotechnol. Adv. 31,",
      "citeRegEx" : "143",
      "shortCiteRegEx" : "143",
      "year" : 2013
    }, {
      "title" : "Surface functionalized gold nanoparticles for drug delivery",
      "author" : [ "J.P. Cheng", "Y.J. Gu", "S.H. Cheng", "W.T. Wong" ],
      "venue" : "J. Biomed. Nanotechnol",
      "citeRegEx" : "145",
      "shortCiteRegEx" : "145",
      "year" : 2013
    }, {
      "title" : "Sizedependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo",
      "author" : [ "K. Huang", "H. Ma", "J. Liu", "S. Huo", "A. Kumar", "T. Wei", "X. Zhang", "S. Jin", "Y. Gan", "P.C. Wang", "S. He", "X.J. Liang" ],
      "venue" : "ACS Nano 6,",
      "citeRegEx" : "146",
      "shortCiteRegEx" : "146",
      "year" : 2012
    }, {
      "title" : "Gold nanoparticles promote osteogenic differentiation of mesenchymal stem cells through p38 MAPK pathway",
      "author" : [ "C. Yi", "D. Liu", "C.C. Fong", "J. Zhang", "M. Yang" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "148",
      "shortCiteRegEx" : "148",
      "year" : 2010
    }, {
      "title" : "Photoregulated release of caged anticancer drugs from gold nanoparticles",
      "author" : [ "S.S. Agasti", "A. Chompoosor", "C.C. You", "P. Ghosh", "C.K. Kim", "V.M. Rotello" ],
      "venue" : "J. Am. Chem",
      "citeRegEx" : "150",
      "shortCiteRegEx" : "150",
      "year" : 2009
    }, {
      "title" : "Gold nanoparticles decorated by amphiphilic block copolymer as efficient system for drug delivery",
      "author" : [ "Z.F. Wang", "L. Jia", "M.H. Li" ],
      "venue" : "J. Biomed. Nanotechnol. 9,",
      "citeRegEx" : "151",
      "shortCiteRegEx" : "151",
      "year" : 2013
    }, {
      "title" : "A study of the nucleation and growth processes in the synthesis of colloidal gold",
      "author" : [ "J. Turkevich", "P.C. Stevenson", "J. Hillier" ],
      "venue" : "Discuss Faraday Soc. 11,",
      "citeRegEx" : "152",
      "shortCiteRegEx" : "152",
      "year" : 1951
    }, {
      "title" : "Integrating a high-force optical trap with gold nanoposts and a robust gold-DNA bond",
      "author" : [ "D.H. Paik", "Y. Seol", "W.A. Halsey", "T.T. Perkins" ],
      "venue" : "Nano Lett",
      "citeRegEx" : "153",
      "shortCiteRegEx" : "153",
      "year" : 2009
    }, {
      "title" : "Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers",
      "author" : [ "R. Hong", "G. Han", "J.M. Fernández", "B. Kim", "N.S. Forbes", "V.M. Rotello" ],
      "venue" : "J. Am. Chem",
      "citeRegEx" : "154",
      "shortCiteRegEx" : "154",
      "year" : 2006
    }, {
      "title" : "Use of a steroid cyclic disulfide anchor in constructing gold nanoparticle-oligonucleotide conjugates",
      "author" : [ "R.L. Letsinger", "R. Elghanian", "G. Viswanadham", "C.A. Mirkin" ],
      "venue" : "Bioconjug. Chem. 11,",
      "citeRegEx" : "155",
      "shortCiteRegEx" : "155",
      "year" : 2000
    }, {
      "title" : "Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells",
      "author" : [ "F. Wang", "Y.C. Wang", "S. Dou", "M.H. Xiong", "T.M. Sun", "J. Wang" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "156",
      "shortCiteRegEx" : "156",
      "year" : 2011
    }, {
      "title" : "A facile in situ generation of dithiocarbamate ligands for stable gold nanoparticleoligonucleotide conjugates",
      "author" : [ "J. Sharma", "R. Chhabra", "H. Yan", "Y. Liu" ],
      "venue" : "Chem. Commun.  18,",
      "citeRegEx" : "157",
      "shortCiteRegEx" : "157",
      "year" : 2008
    }, {
      "title" : "Superior penetration and retention behavior of 50 nm gold nanoparticles in tumors",
      "author" : [ "S. Huo", "H. Ma", "K. Huang", "J. Liu", "T. Wei", "S. Jin", "J. Zhang", "S. He", "X.J. Liang" ],
      "venue" : "Cancer Res",
      "citeRegEx" : "159",
      "shortCiteRegEx" : "159",
      "year" : 2013
    }, {
      "title" : "Controlling assembly of paired gold clusters within",
      "author" : [ "C. Sun", "H. Yang", "Y. Yuan", "X. Tian", "L. Wang", "Y. Guo", "L. Xu", "J. Lei", "N. Gao", "G.J. Anderson", "X.J. Liang", "C. Chen", "Y. Zhao", "G. Nie" ],
      "venue" : "J. Biomed. Nanotechnol. 12,",
      "citeRegEx" : "160",
      "shortCiteRegEx" : "160",
      "year" : 2016
    }, {
      "title" : "Molecular origin of cytotoxicity and surface effects",
      "author" : [ "A.M. Alkilany", "P.K. Nagaria", "C.R. Hexel", "T.J. Shaw", "C.J. Murphy", "M.D. Wyatt", "Cellular uptake", "cytotoxicity of gold nanorods" ],
      "venue" : "Small 5, 701",
      "citeRegEx" : "161",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Nanocarriers as an emerging platform for cancer therapy",
      "author" : [ "D. Peer", "J.M. Karp", "S. Hong", "O.C. Farokhzad", "R. Margalit", "R. Langer" ],
      "venue" : "Nat. Nanotechnol",
      "citeRegEx" : "162",
      "shortCiteRegEx" : "162",
      "year" : 2007
    }, {
      "title" : "Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment",
      "author" : [ "A. Kumar", "H. Ma", "X. Zhang", "K. Huang", "S. Jin", "J. Liu", "T. Wei", "W. Cao", "G. Zou", "X.J. Liang" ],
      "venue" : "Biomaterials 33,",
      "citeRegEx" : "163",
      "shortCiteRegEx" : "163",
      "year" : 2012
    }, {
      "title" : "Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere",
      "author" : [ "J.L. Vivero-Escoto", "I.I. Slowing", "C.W. Wu", "V.S.Y. Lin" ],
      "venue" : "J. Am. Chem",
      "citeRegEx" : "165",
      "shortCiteRegEx" : "165",
      "year" : 2009
    }, {
      "title" : "Discrete thermally responsive hydrogelcoated gold nanoparticles for use as drug-delivery vehicles",
      "author" : [ "J.H. Kim", "T.R. Lee" ],
      "venue" : "Drug Dev. Res. 67,",
      "citeRegEx" : "166",
      "shortCiteRegEx" : "166",
      "year" : 2006
    }, {
      "title" : "Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug",
      "author" : [ "M. Prabaharan", "J.J. Grailer", "S. Pilla", "D.A. Steeber", "S. Gong" ],
      "venue" : "delivery. Biomaterials",
      "citeRegEx" : "167",
      "shortCiteRegEx" : "167",
      "year" : 2009
    }, {
      "title" : "Nanoshells: Gifts in a gold wrapper",
      "author" : [ "M.L. Brongersma", "Nanoscale photonics" ],
      "venue" : "Nat. Mater. 2, 296",
      "citeRegEx" : "168",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "Gold nanoshell nanomicelles for potential magnetic resonance imaging, light-triggered drug release, and photothermal therapy",
      "author" : [ "Y. Ma", "X. Liang", "S. Tong", "G. Bao", "Q. Ren", "Z. Dai" ],
      "venue" : "Adv. Funct. Mater. 23,",
      "citeRegEx" : "169",
      "shortCiteRegEx" : "169",
      "year" : 2013
    }, {
      "title" : "A drug cocktail to fight breast tumors via a single irradiation with near-infrared laser light",
      "author" : [ "H. Liu", "T. Liu", "X. Wu", "L. Li", "L. Tan", "D. Chen", "F. Tang", "Targeting gold nanoshells on silica nanorattles" ],
      "venue" : "Adv. Mater. 24, 755",
      "citeRegEx" : "170",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Optical-properties of composite membranes containing arrays of nanoscopic gold cylinders",
      "author" : [ "C.A. Foss", "G.L. Hornyak", "J.A. Stockert", "C.R. Martin" ],
      "venue" : "J. Phys. Chem",
      "citeRegEx" : "171",
      "shortCiteRegEx" : "171",
      "year" : 1992
    }, {
      "title" : "Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods",
      "author" : [ "X. Huang", "I.H. El-Sayed", "W. Qian", "M.A. El-Sayed" ],
      "venue" : "J. Am. Chem",
      "citeRegEx" : "172",
      "shortCiteRegEx" : "172",
      "year" : 2006
    }, {
      "title" : "Surface chemistry-mediated penetration and gold nanorod thermotherapy in multicellular tumor spheroids",
      "author" : [ "S. Jin", "X. Ma", "H. Ma", "K. Zheng", "J. Liu", "S. Hou", "J. Meng", "P.C. Wang", "X. Wu", "X.J. Liang" ],
      "venue" : "Nanoscale 5,",
      "citeRegEx" : "173",
      "shortCiteRegEx" : "173",
      "year" : 2013
    }, {
      "title" : "Their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions",
      "author" : [ "A.M. Alkilany", "L.B. Thompson", "S.P. Boulos", "P.N. Sisco", "C.J. Murphy", "Gold nanorods" ],
      "venue" : "Adv. Drug Deliv. Rev. 64, 190",
      "citeRegEx" : "174",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Synthesis of near-infrared responsive gold nanorod/PNIPAAm Core/Shell nanohybridsvia surface initiated ATRP for smart drug delivery. Macromol",
      "author" : [ "Q. Wei", "J. Ji", "J. Shen" ],
      "venue" : "Rapid. Commun. 29,",
      "citeRegEx" : "175",
      "shortCiteRegEx" : "175",
      "year" : 2008
    }, {
      "title" : "Hamad-Schifferli, Selective release of multiple DNA oligonucleotides from gold nanorods",
      "author" : [ "A. Wijaya", "S.B. Schaffer", "I.G. Pallares" ],
      "venue" : "ACS Nano 3,",
      "citeRegEx" : "176",
      "shortCiteRegEx" : "176",
      "year" : 2008
    }, {
      "title" : "Gold nanorods conjugated with doxorubicin and cRGD for combined anticancer drug delivery and PET imaging",
      "author" : [ "Y. Xiao", "H. Hong", "V.Z. Matson", "A. Javadi", "W. Xu", "Y. Yang", "Y. Zhang", "J.W. Engle", "R.J. Nickles", "W. Cai", "D.A. Steeber", "S. Gong" ],
      "venue" : "Theranostics 2,",
      "citeRegEx" : "177",
      "shortCiteRegEx" : "177",
      "year" : 2012
    }, {
      "title" : "a sustained drug delivery carrier for improved anticancer therapy",
      "author" : [ "R. Venkatesan", "A. Pichaimani", "K. Hari", "P.K. Balasubramanian", "J. Kulandaivel", "K. Premkumar", "Doxorubicin conjugated gold  nanorods" ],
      "venue" : "J. Mater. Chem. B 1, 1010",
      "citeRegEx" : "178",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "A one-step approach to the large-scale synthesis of metal nanostructures with hollow interiors",
      "author" : [ "Y. Sun", "B.T. Mayers", "Y. Xia", "Template-engaged replacement reaction" ],
      "venue" : "Nano Lett. 2, 481",
      "citeRegEx" : "179",
      "shortCiteRegEx" : null,
      "year" : 2002
    }, {
      "title" : "An enzyme-sensitive probe for photoacoustic imaging and fluorescence detection of protease activity",
      "author" : [ "X. Xia", "M. Yang", "L.K. Oetjen", "Y. Zhang", "Q. Li", "J. Chen", "Y. Xia" ],
      "venue" : "Nanoscale 3,",
      "citeRegEx" : "180",
      "shortCiteRegEx" : "180",
      "year" : 2011
    }, {
      "title" : "The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine",
      "author" : [ "J.R. Hornick", "J. Xu", "S. Vangveravong", "Z. Tu", "J.B. Mitchem", "D. Spitzer", "P. Goedegebuure", "R.H. Mach", "W.G. Hawkins" ],
      "venue" : "Mol. Cancer 9,",
      "citeRegEx" : "181",
      "shortCiteRegEx" : "181",
      "year" : 2010
    }, {
      "title" : "Therapeutic and diagnostic applications of sigma ligands",
      "author" : [ "A. van Waarde", "A.A. Rybczynska", "N.K. Ramakrishnan", "K. Ishiwata", "P.H. Elsinga", "R.A.J.O. Dierckx", "Sigma receptors in oncology" ],
      "venue" : "Curr. Pharm. Des. 16, 3519",
      "citeRegEx" : "182",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "A new platform for targeting cancer cells via sigma-2 receptors",
      "author" : [ "Y. Wang", "J. Xu", "X. Xia", "M. Yang", "S. Vangveravong", "J. Chen", "R.H. Mach", "Y. Xia", "SV119-gold nanocage conjugates" ],
      "venue" : "Nanoscale 4, 421",
      "citeRegEx" : "183",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Hydrogels for biomedical applications",
      "author" : [ "A.S. Hoffman" ],
      "venue" : "Adv. Drug Deliv. Rev. 64,",
      "citeRegEx" : "185",
      "shortCiteRegEx" : "185",
      "year" : 2002
    }, {
      "title" : "A new theranostic system based on gold nanocages and phase-change materials with unique features for photoacoustic imaging and controlled release",
      "author" : [ "G.D. Moon", "S.-W. Choi", "X. Cai", "W. Li", "E.C. Cho", "U. Jeong", "L.V. Wang", "Y. Xia" ],
      "venue" : "J. Am. Chem",
      "citeRegEx" : "186",
      "shortCiteRegEx" : "186",
      "year" : 2011
    }, {
      "title" : "Phase change materials for smart textiles-An overview",
      "author" : [ "S. Mondal" ],
      "venue" : "Appl. Therm. Eng. 28,",
      "citeRegEx" : "187",
      "shortCiteRegEx" : "187",
      "year" : 2007
    }, {
      "title" : "Magnetism in medicine",
      "author" : [ "M.W. Freeman", "A. Arrott", "J.H.L. Watson" ],
      "venue" : "J. Appl. Phys. 31,",
      "citeRegEx" : "188",
      "shortCiteRegEx" : "188",
      "year" : 1960
    }, {
      "title" : "Interaction between ketoconazole and human serum albumin on epoxy modified magnetic nanoparticles for drug delivery",
      "author" : [ "E. Maltas", "M. Ozmen", "B. Yildirmer", "S. Kucukkolbasi", "S. Yildiz" ],
      "venue" : "J. Nanosci. Nanotechnol",
      "citeRegEx" : "191",
      "shortCiteRegEx" : "191",
      "year" : 2013
    }, {
      "title" : "A versatile nanotool for cancer cell imaging, targeted drug delivery and synergistic effect of drug and hyperthermia mediated cancer therapy",
      "author" : [ "B. Sivakumar", "R.G. Aswathy", "R. Sreejith", "Y. Nagaoka", "S. Iwai", "M. Suzuki", "T. Fujuda", "T. Hasumura", "Y. Yoshida", "T. Maekawa", "D.N. Sakthikumar", "Bacterial exopolysaccharide based magnetic nanoparticles" ],
      "venue" : "J. Biomed. Nanotechnol. 10, 885",
      "citeRegEx" : "192",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Magnetic micelles as a potential platform for dual targeted drug delivery in cancer therapy",
      "author" : [ "C. Huang", "Z. Tang", "Y. Zhou", "X. Zhou", "Y. Jin", "D. Li" ],
      "venue" : "Int. J. Pharm. 429,",
      "citeRegEx" : "193",
      "shortCiteRegEx" : "193",
      "year" : 2012
    }, {
      "title" : "The silica coating regulations with a single core for different core sizes and shell thicknesses",
      "author" : [ "H.L. Ding", "Y.X. Zhang", "S. Wang", "J.M. Xu", "S.C. Xu", "G.H. Li", "Fe3O4@SiO2 core/shell nanoparticles" ],
      "venue" : "Chem. Mater. 24, 4572",
      "citeRegEx" : "194",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "A flexible drug delivery chip for the magnetically-controlled release of anti-epileptic drugs",
      "author" : [ "W.C. Huang", "S.H. Hu", "K.H. Liu", "S.Y. Chen", "D.M. Liu" ],
      "venue" : "J. Control Release 139,",
      "citeRegEx" : "195",
      "shortCiteRegEx" : "195",
      "year" : 2009
    }, {
      "title" : "Synthesis and application in drug delivery of hollow-core-double-shell magnetic iron oxide/silica/calcium silicate nanocomposites",
      "author" : [ "B.Q. Lu", "Y.J. Zhu", "G.F. Cheng", "Y.J. Ruan" ],
      "venue" : "Mater. Lett. 104,",
      "citeRegEx" : "196",
      "shortCiteRegEx" : "196",
      "year" : 2013
    }, {
      "title" : "Small multifunctional nanoclusters (nanoroses) for targeted cellular imaging and therapy",
      "author" : [ "L.L. Ma", "M.D. Feldman", "J.M. Tam", "A.S. Paranjape", "K.K. Cheruku", "T.A. Larson", "J.O. Tam", "D.R. Ingram", "V. Paramita", "J.W. Villard", "J.T. Jenkins", "T. Wang", "G.D. Clarke", "R. Asmis", "K. Sokolov", "B. Chandrasekar", "T.E. Milner", "K.P. Johnston" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "197",
      "shortCiteRegEx" : "197",
      "year" : 2009
    }, {
      "title" : "Dumbbell-like  Au–Fe3O4 nanoparticles for target-specific platin delivery",
      "author" : [ "C.J. Xu", "B.D. Wang", "S.H. Sun" ],
      "venue" : "J. Am. Chem",
      "citeRegEx" : "198",
      "shortCiteRegEx" : "198",
      "year" : 2009
    }, {
      "title" : "Cisplatin drug delivery using gold-coated iron oxide nanoparticles for enhanced tumour targeting with external magnetic fields",
      "author" : [ "A.J. Wagstaff", "S.D. Brown", "M.R. Holden", "G.E. Craig", "J.A. Plumb", "R.E. Brown" ],
      "venue" : "Inorg. Chim. Acta. 393,",
      "citeRegEx" : "199",
      "shortCiteRegEx" : "199",
      "year" : 2012
    }, {
      "title" : "Synthesis of a multifunctional nanocomposite with magnetic, mesoporous, and near-IR absorption properties",
      "author" : [ "Z.H. Xu", "C.X. Li", "X.J. Kang", "D.M. Yang", "P.P. Yang", "Z.Y. Hou" ],
      "venue" : "J. Phys. Chem. C 114,",
      "citeRegEx" : "200",
      "shortCiteRegEx" : "200",
      "year" : 2010
    }, {
      "title" : "Design and construction of polymerized-glucose coated  Fe3O4 magnetic nanoparticles for delivery of aspirin",
      "author" : [ "C.Y. Chen", "X.C. Jiang", "Y.V. Kaneti", "A.B. Yu" ],
      "venue" : "Powder Technol. 236,",
      "citeRegEx" : "201",
      "shortCiteRegEx" : "201",
      "year" : 2013
    }, {
      "title" : "Thermoresponsive magnetic composite nanomaterials for multimodal cancer therapy",
      "author" : [ "S. Purushotham", "R.V. Ramanujan" ],
      "venue" : "Acta Biomater. 6,",
      "citeRegEx" : "202",
      "shortCiteRegEx" : "202",
      "year" : 2010
    }, {
      "title" : "Multifunctional SPIO/DOX-loaded wormlike  polymer vesicles for cancer therapy and MR imaging",
      "author" : [ "X. Yang", "J.J. Grailer", "I.J. Rowland", "A. Javadi", "S.A. Hurley", "D.A. Steeber" ],
      "venue" : "Biomaterials 31,",
      "citeRegEx" : "203",
      "shortCiteRegEx" : "203",
      "year" : 2010
    }, {
      "title" : "Functionalized polymersomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and MR imaging",
      "author" : [ "W.H. Chiang", "W.C. Huang", "C.W. Chang", "M.Y. Shen", "Z.F. Shih", "Y.F. Huang", "S.C. Lin", "H.C. Chiu" ],
      "venue" : "J. Control Release 168,",
      "citeRegEx" : "204",
      "shortCiteRegEx" : "204",
      "year" : 2013
    }, {
      "title" : "Enhancement effect of nano  Fe3O4 to the drug accumulation of doxorubicin in cancer cells",
      "author" : [ "R.Y. Zhang", "C.H. Wu", "X.M. Wang", "Q. Sun", "B.A. Chen", "X.M. Li" ],
      "venue" : "Mater. Sci. Eng. C",
      "citeRegEx" : "206",
      "shortCiteRegEx" : "206",
      "year" : 2009
    }, {
      "title" : "Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy",
      "author" : [ "F. Dilnawaz", "A. Singh", "C. Mohanty", "S.K. Sahoo" ],
      "venue" : "Biomaterial 31,",
      "citeRegEx" : "207",
      "shortCiteRegEx" : "207",
      "year" : 2010
    }, {
      "title" : "Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors",
      "author" : [ "A.K. Gupta", "A.S. Curtis" ],
      "venue" : "Biomaterial 25,",
      "citeRegEx" : "208",
      "shortCiteRegEx" : "208",
      "year" : 2004
    }, {
      "title" : "Simultaneous intracellular delivery of targeting antibodies and functional nanoparticles with engineered protein Gsystem",
      "author" : [ "Y.T. Lim", "M.Y. Cho", "J.M. Lee", "S.J. Chung", "B.H. Chung" ],
      "venue" : "Biomaterials 30,",
      "citeRegEx" : "209",
      "shortCiteRegEx" : "209",
      "year" : 2009
    } ],
    "referenceMentions" : [ {
      "referenceID" : 4,
      "context" : "In the past decade, mesoporous silica nanoparticles have attracted considerable attention for their potential biomedical applications due to their tailored mesoporous structure, large surface area, good biocompatibility, and ease of surface functionalization.(7) 9 Due to these unique properties, mesoporous silica nanoparticles have become attractive nanocontainers for drug deliver systems.",
      "startOffset" : 259,
      "endOffset" : 262
    }, {
      "referenceID" : 12,
      "context" : "32 Iron oxide magnetic particles have been combined with mesoporous silica matrixes to overcome these limitations, representing a significant advance in the drug delivery field.(15) 33 These iron oxide/mesoporous silica composite materials have potential for use in anticancer drug delivery.",
      "startOffset" : 177,
      "endOffset" : 181
    }, {
      "referenceID" : 39,
      "context" : "they displayed rapid drug release at higher temperatures (on phase) and ceased drug release at lower temperatures (off phase).(49) Schlossbauer(50) and Ruiz-Hernández(51) developed a novel DNA-based thermo-responsive drug delivery system in which biotin-labeled DNA double strands and DNA/magnetic nanoparticles were used to cap the pores of mesoporous silica nanoparticles.",
      "startOffset" : 126,
      "endOffset" : 130
    }, {
      "referenceID" : 75,
      "context" : "engineered various types of hybrid vesicles consisting of functionalized (PEG-lipid coated) QDs encapsulated into the aqueous core of a variety of liposomes (f-QD-L) for the simultaneous delivery of therapeutic and diagnostic agents in vivo for systemic solid tumor targeting and labeling.(93) 96 Cho et al.",
      "startOffset" : 289,
      "endOffset" : 293
    }, {
      "referenceID" : 76,
      "context" : "These self-tracking siRNA delivery nanoparticles will also facilitate monitoring in future in vivo gene silencing studies.(94) 97 Carbon nanotubes have also emerged as a new alternative and efficient tool for transporting and translocating therapeutic molecules.",
      "startOffset" : 122,
      "endOffset" : 126
    }, {
      "referenceID" : 77,
      "context" : "Figure 2(E) shows the bright fluorescence observed after the six-day circulation of the CNT-QDs; strong fluorescence was observed in the liver, kidneys, stomach and intestine, indicating that the multi-walled nanotube nanocarriers mainly accumulated in these organs.(95) Although QDs have become increasingly attractive in drug delivery and tagging due to their unique properties, such as small size and easily modified surfaces, some problems remain.",
      "startOffset" : 266,
      "endOffset" : 270
    }, {
      "referenceID" : 21,
      "context" : "109 Hollow carbon nanoparticles show promise as drug delivery systems due to their desirable chemical and physical properties, such as high surface areas and excellent flow performances.(26) This type of drug carrier exhibits controlled drug release and targeting, meeting the demands of modern diagnosis and therapy.",
      "startOffset" : 186,
      "endOffset" : 190
    }, {
      "referenceID" : 94,
      "context" : "reported that a fullerene-based system enabled the slow release of the anticancer drug paclitaxel.(115) Fullerene and paclitaxel were chemically functionalized to incorporate a cleavable ester bond between them.",
      "startOffset" : 98,
      "endOffset" : 103
    }, {
      "referenceID" : 97,
      "context" : "117 Moreover, fullerenes functionalized with DNA exhibit superior efficiency compared to commercially available lipid-based vectors.(118) In the first in vivo gene delivery experiment with fullerene derivatives, cationic tetra aminofullerene, which has high water-solubility, was used to complex DNA, and its efficiency and toxicity were compared to those of Lipofectin.",
      "startOffset" : 132,
      "endOffset" : 137
    }, {
      "referenceID" : 111,
      "context" : "The extended release of the drug from the nanodiamond-DOX conjugates yielded a steady, lethal dose of drug in the cell, in contrast to free DOX.(135) Due to their resistance to chemotherapy, tumors treated with DOX or PBS exhibited only limited size reductions, while tumors treated with nanodiamond-DOX exhibited significant size reductions (Fig.",
      "startOffset" : 144,
      "endOffset" : 149
    }, {
      "referenceID" : 113,
      "context" : "133 Nanodiamond-PEI800-mediated delivery of siRNA to silence GFP expression yielded increased efficacy compared to Lipofectamine under physiological conditions.(137) A variety of other cargos have been delivered by nanodiamonds, including covalently attached drugs,138 proteins,139 small molecules under acidic conditions (which are",
      "startOffset" : 160,
      "endOffset" : 165
    }, {
      "referenceID" : 157,
      "context" : "186 However, more than 40% of the active compounds identified by combinatorial screening programs are poorly soluble in water.(187) Thus, novel systems that are well suited for the encapsulation of both hydrophilic and hydrophobic drugs must be identified.",
      "startOffset" : 126,
      "endOffset" : 131
    }, {
      "referenceID" : 173,
      "context" : "Tetraheptylammonium-capped Fe3O4 nanoparticles efficiently enhanced DOX accumulation in target cancer, resulting in significantly enhanced DOX uptake in leukemia K562 cells in vitro.(206) High entrapment efficiency and sustained release of anticancer drugs can be achieved with glycerol monooleate-coated magnetic nanoparticles.",
      "startOffset" : 182,
      "endOffset" : 187
    }, {
      "referenceID" : 175,
      "context" : "Lactoferrin- or ceruloplasmin-derivatized Fe3O4 nanoparticles target the surfaces of cells with little effect on the cytoskeleton and thus may serve as a non-toxic means of drug targeting.(208) An engineered protein G system as a vehicle for the simultaneous intracellular delivery of functional nanoparticles and targeting antibodies has been reported.",
      "startOffset" : 188,
      "endOffset" : 193
    } ],
    "year" : 2015,
    "abstractText" : "Shizhu Chen1, Xiaohong Hao1, Xingjie Liang2, Qun Zhang1, Cuimiao Zhang1, Guoqiang Zhou1, Shigang Shen1, Guang Jia1 ∗, and Jinchao Zhang1 ∗ 1Key Laboratory of Chemical Biology of Hebei Province, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, College of Chemistry and Environmental Science, Hebei University, Baoding 071002, P. R. China 2CAS Key Lab of Nanomaterials Bioeffects and Nanosafety, National Center for Nanoscience and Technology of China, Beijing, 100190, P. R. China",
    "creator" : null
  }
}